289 results on '"Ak N"'
Search Results
102. BROAD ABSORPTION LINE VARIABILITY ON MULTI-YEAR TIMESCALES IN A LARGE QUASAR SAMPLE
- Author
-
Filiz Ak, N., primary, Brandt, W. N., additional, Hall, P. B., additional, Schneider, D. P., additional, Anderson, S. F., additional, Hamann, F., additional, Lundgren, B. F., additional, Myers, Adam D., additional, Pâris, I., additional, Petitjean, P., additional, Ross, Nicholas P., additional, Shen, Yue, additional, and York, Don, additional
- Published
- 2013
- Full Text
- View/download PDF
103. Broad absorption line quasars with redshifted troughs: high-velocity infall or rotationally dominated outflows?
- Author
-
Hall, P. B., primary, Brandt, W. N., additional, Petitjean, P., additional, Pâris, I., additional, Filiz Ak, N., additional, Shen, Yue, additional, Gibson, R. R., additional, Aubourg, É., additional, Anderson, S. F., additional, Schneider, D. P., additional, Bizyaev, D., additional, Brinkmann, J., additional, Malanushenko, E., additional, Malanushenko, V., additional, Myers, A. D., additional, Oravetz, D. J., additional, Ross, N. P., additional, Shelden, A., additional, Simmons, A. E., additional, Streblyanska, A., additional, Weaver, B. A., additional, and York, D. G., additional
- Published
- 2013
- Full Text
- View/download PDF
104. THE BARYON OSCILLATION SPECTROSCOPIC SURVEY OF SDSS-III
- Author
-
Dawson, Kyle S., primary, Schlegel, David J., additional, Ahn, Christopher P., additional, Anderson, Scott F., additional, Aubourg, Éric, additional, Bailey, Stephen, additional, Barkhouser, Robert H., additional, Bautista, Julian E., additional, Beifiori, Alessandra, additional, Berlind, Andreas A., additional, Bhardwaj, Vaishali, additional, Bizyaev, Dmitry, additional, Blake, Cullen H., additional, Blanton, Michael R., additional, Blomqvist, Michael, additional, Bolton, Adam S., additional, Borde, Arnaud, additional, Bovy, Jo, additional, Brandt, W. N., additional, Brewington, Howard, additional, Brinkmann, Jon, additional, Brown, Peter J., additional, Brownstein, Joel R., additional, Bundy, Kevin, additional, Busca, N. G., additional, Carithers, William, additional, Carnero, Aurelio R., additional, Carr, Michael A., additional, Chen, Yanmei, additional, Comparat, Johan, additional, Connolly, Natalia, additional, Cope, Frances, additional, Croft, Rupert A. C., additional, Cuesta, Antonio J., additional, da Costa, Luiz N., additional, Davenport, James R. A., additional, Delubac, Timothée, additional, de Putter, Roland, additional, Dhital, Saurav, additional, Ealet, Anne, additional, Ebelke, Garrett L., additional, Eisenstein, Daniel J., additional, Escoffier, S., additional, Fan, Xiaohui, additional, Filiz Ak, N., additional, Finley, Hayley, additional, Font-Ribera, Andreu, additional, Génova-Santos, R., additional, Gunn, James E., additional, Guo, Hong, additional, Haggard, Daryl, additional, Hall, Patrick B., additional, Hamilton, Jean-Christophe, additional, Harris, Ben, additional, Harris, David W., additional, Ho, Shirley, additional, Hogg, David W., additional, Holder, Diana, additional, Honscheid, Klaus, additional, Huehnerhoff, Joe, additional, Jordan, Beatrice, additional, Jordan, Wendell P., additional, Kauffmann, Guinevere, additional, Kazin, Eyal A., additional, Kirkby, David, additional, Klaene, Mark A., additional, Kneib, Jean-Paul, additional, Le Goff, Jean-Marc, additional, Lee, Khee-Gan, additional, Long, Daniel C., additional, Loomis, Craig P., additional, Lundgren, Britt, additional, Lupton, Robert H., additional, Maia, Marcio A. G., additional, Makler, Martin, additional, Malanushenko, Elena, additional, Malanushenko, Viktor, additional, Mandelbaum, Rachel, additional, Manera, Marc, additional, Maraston, Claudia, additional, Margala, Daniel, additional, Masters, Karen L., additional, McBride, Cameron K., additional, McDonald, Patrick, additional, McGreer, Ian D., additional, McMahon, Richard G., additional, Mena, Olga, additional, Miralda-Escudé, Jordi, additional, Montero-Dorta, Antonio D., additional, Montesano, Francesco, additional, Muna, Demitri, additional, Myers, Adam D., additional, Naugle, Tracy, additional, Nichol, Robert C., additional, Noterdaeme, Pasquier, additional, Nuza, Sebastián E., additional, Olmstead, Matthew D., additional, Oravetz, Audrey, additional, Oravetz, Daniel J., additional, Owen, Russell, additional, Padmanabhan, Nikhil, additional, Palanque-Delabrouille, Nathalie, additional, Pan, Kaike, additional, Parejko, John K., additional, Pâris, Isabelle, additional, Percival, Will J., additional, Pérez-Fournon, Ismael, additional, Pérez-Ràfols, Ignasi, additional, Petitjean, Patrick, additional, Pfaffenberger, Robert, additional, Pforr, Janine, additional, Pieri, Matthew M., additional, Prada, Francisco, additional, Price-Whelan, Adrian M., additional, Raddick, M. Jordan, additional, Rebolo, Rafael, additional, Rich, James, additional, Richards, Gordon T., additional, Rockosi, Constance M., additional, Roe, Natalie A., additional, Ross, Ashley J., additional, Ross, Nicholas P., additional, Rossi, Graziano, additional, Rubiño-Martin, J. A., additional, Samushia, Lado, additional, Sánchez, Ariel G., additional, Sayres, Conor, additional, Schmidt, Sarah J., additional, Schneider, Donald P., additional, Scóccola, C. G., additional, Seo, Hee-Jong, additional, Shelden, Alaina, additional, Sheldon, Erin, additional, Shen, Yue, additional, Shu, Yiping, additional, Slosar, Anže, additional, Smee, Stephen A., additional, Snedden, Stephanie A., additional, Stauffer, Fritz, additional, Steele, Oliver, additional, Strauss, Michael A., additional, Streblyanska, Alina, additional, Suzuki, Nao, additional, Swanson, Molly E. C., additional, Tal, Tomer, additional, Tanaka, Masayuki, additional, Thomas, Daniel, additional, Tinker, Jeremy L., additional, Tojeiro, Rita, additional, Tremonti, Christy A., additional, Vargas Magaña, M., additional, Verde, Licia, additional, Viel, Matteo, additional, Wake, David A., additional, Watson, Mike, additional, Weaver, Benjamin A., additional, Weinberg, David H., additional, Weiner, Benjamin J., additional, West, Andrew A., additional, White, Martin, additional, Wood-Vasey, W. M., additional, Yeche, Christophe, additional, Zehavi, Idit, additional, Zhao, Gong-Bo, additional, and Zheng, Zheng, additional
- Published
- 2012
- Full Text
- View/download PDF
105. The Sloan Digital Sky Survey quasar catalog: ninth data release
- Author
-
Pâris, I., primary, Petitjean, P., additional, Aubourg, É., additional, Bailey, S., additional, Ross, N. P., additional, Myers, A. D., additional, Strauss, M. A., additional, Anderson, S. F., additional, Arnau, E., additional, Bautista, J., additional, Bizyaev, D., additional, Bolton, A. S., additional, Bovy, J., additional, Brandt, W. N., additional, Brewington, H., additional, Browstein, J. R., additional, Busca, N., additional, Capellupo, D., additional, Carithers, W., additional, Croft, R. A. C., additional, Dawson, K., additional, Delubac, T., additional, Ebelke, G., additional, Eisenstein, D. J., additional, Engelke, P., additional, Fan, X., additional, Filiz Ak, N., additional, Finley, H., additional, Font-Ribera, A., additional, Ge, J., additional, Gibson, R. R., additional, Hall, P. B., additional, Hamann, F., additional, Hennawi, J. F., additional, Ho, S., additional, Hogg, D. W., additional, Ivezić, Ž., additional, Jiang, L., additional, Kimball, A. E., additional, Kirkby, D., additional, Kirkpatrick, J. A., additional, Lee, K.-G., additional, Le Goff, J.-M., additional, Lundgren, B., additional, MacLeod, C. L., additional, Malanushenko, E., additional, Malanushenko, V., additional, Maraston, C., additional, McGreer, I. D., additional, McMahon, R. G., additional, Miralda-Escudé, J., additional, Muna, D., additional, Noterdaeme, P., additional, Oravetz, D., additional, Palanque-Delabrouille, N., additional, Pan, K., additional, Perez-Fournon, I., additional, Pieri, M. M., additional, Richards, G. T., additional, Rollinde, E., additional, Sheldon, E. S., additional, Schlegel, D. J., additional, Schneider, D. P., additional, Slosar, A., additional, Shelden, A., additional, Shen, Y., additional, Simmons, A., additional, Snedden, S., additional, Suzuki, N., additional, Tinker, J., additional, Viel, M., additional, Weaver, B. A., additional, Weinberg, D. H., additional, White, M., additional, Wood-Vasey, W. M., additional, and Yèche, C., additional
- Published
- 2012
- Full Text
- View/download PDF
106. BROAD ABSORPTION LINE DISAPPEARANCE ON MULTI-YEAR TIMESCALES IN A LARGE QUASAR SAMPLE
- Author
-
Filiz Ak, N., primary, Brandt, W. N., additional, Hall, P. B., additional, Schneider, D. P., additional, Anderson, S. F., additional, Gibson, R. R., additional, Lundgren, B. F., additional, Myers, A. D., additional, Petitjean, P., additional, Ross, Nicholas P., additional, Shen, Yue, additional, York, D. G., additional, Bizyaev, D., additional, Brinkmann, J., additional, Malanushenko, E., additional, Oravetz, D. J., additional, Pan, K., additional, Simmons, A. E., additional, and Weaver, B. A., additional
- Published
- 2012
- Full Text
- View/download PDF
107. Fever of unknown origin in internal medicine
- Author
-
Küçükardaly Y and Koçak N
- Subjects
trends ,therapy ,Physician-Patient Relations ,Attitude of Health Personnel ,diagnosis ,lcsh:R ,India ,lcsh:Medicine ,Fever of Unknown Origin ,Physician′s Practice Patterns ,Internal Medicine ,standards ,Human ,Quality of Health Care - Published
- 2002
108. Orbits of six late-type active-chromosphere binaries
- Author
-
Griffin, R. F., primary and Filiz Ak, N., additional
- Published
- 2010
- Full Text
- View/download PDF
109. Alstonia Costricta - A Multicentric Clinical Verification Study
- Author
-
Chakraborty, P S, primary, Khurana, A, additional, Singh, J P, additional, Rai, M Kumar, additional, Singh, Pramodji, additional, Vichitra, A K, additional, Singh, AK N, additional, Chakraborty, Deepa, additional, and Siddiqui, V A, additional
- Published
- 2009
- Full Text
- View/download PDF
110. High Resolution Coude Echelle Spectroscopy of IX Per
- Author
-
Ak, N. Filiz, primary, Eker, Z., additional, Ak, H., additional, Küçük, I., additional, and Stempels, Eric, additional
- Published
- 2009
- Full Text
- View/download PDF
111. New absolute magnitude calibrations for detached binaries
- Author
-
Bilir, S., primary, Ak, T., additional, Soydugan, E., additional, Soydugan, F., additional, Yaz, E., additional, Filiz Ak, N., additional, Eker, Z., additional, Demircan, O., additional, and Helvacı, M., additional
- Published
- 2008
- Full Text
- View/download PDF
112. A catalogue of chromospherically active binary stars (third edition)
- Author
-
Eker, Z., primary, Ak, N. Filiz, additional, Bilir, S., additional, Doğru, D., additional, Tüysüz, M., additional, Soydugan, E., additional, Bakış, H., additional, Uğraş, B., additional, Soydugan, F., additional, Erdem, A., additional, and Demircan, O., additional
- Published
- 2008
- Full Text
- View/download PDF
113. Blatta Orientails
- Author
-
Chakraborty, P S, primary, Singh, J P, additional, Rai, M K, additional, Singh, pramodiji, additional, Singh, AK N, additional, Chakraborty, Deepa, additional, Singh, D K, additional, Singh, Hari, additional, and Siddiqui, V A, additional
- Published
- 2008
- Full Text
- View/download PDF
114. Negative Effect of Immediate Hyperbaric Oxygen Therapy in Acute Acoustic Trauma
- Author
-
??akir, Burak ??m??r, primary, Ercan, Ibrahim, additional, Civelek, ??enol, additional, K??rpinar, ??efika, additional, Toklu, Ak??n Sava??, additional, Gedik, ??zlem, additional, I??ik, G??khan, additional, Sayin, Ibrahim, additional, and Turgut, Suat, additional
- Published
- 2006
- Full Text
- View/download PDF
115. Blood Loss Evaluation in Children Under the Age of 11 with Femoral Shaft Fractures Patients with Isolated Versus Multiple Injuries
- Author
-
Unal, Vuslat Sema, primary, Gulcek, Murat, additional, Unveren, Zafer, additional, Karakuyu, Ak??n, additional, and Ucaner, Ahmet, additional
- Published
- 2006
- Full Text
- View/download PDF
116. Wealth and wealth inequality in adult HIV prevalence
- Author
-
Gary Gaumer, Roya Sherafat-Kazemzadeh, Monica Jordan, and AK Nandakumar
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
# Background Studies investigating a correlation between economic status of household (wealth or income) and human immunodeficiency virus (HIV) prevalence have shown relationships ranging from insignificant to strong-positive. Using data from over 400,000 Demographic and Health Surveys (DHS) respondents in 29 African low- and middle-income countries receiving assistance from the US President’s Emergency Plan for AIDS Relief (PEPFAR), this study was conducted on HIV prevalence as it relates to wealth and wealth inequality. # Methods Individual-level Demographic and Health Surveys (DHS) data was obtained for 2010-2016 from 29 PEPFAR recipient countries through the DHS data portal. These data link survey responses with the HIV test results from biomarker data. To adjust for sample selection bias in the observational data, an inverse probability reweighting (IPW) technique was used to create sample weights and estimate model parameters. # Results After reweighting, the wealth effects on prevalence are smaller, often statistically insignificant or inconsistent, indicating that higher levels of wealth are not associated with higher HIV prevalence. Low wealth (being poor) is associated with a higher risk for some segments of the population. The growing interest in the literature of "wealth" as a driver of the maturing HIV epidemic may be an artifact of the longer survival of wealthy people in the DHS observational data. The extent of wealth inequality in the region of residence is consistently a positive driver of higher prevalence. In all three wealth categories (tertiles of high, medium, low), more wealth inequality in a region is consistently associated with a higher HIV prevalence, other things remaining the same. # Conclusions The findings of the study suggest that supply-oriented policies (e.g. distribution of providers and programs) to integrate PEPFAR activities into country health systems targeted to areas where wealth inequality is high and where pockets of low-wealth populations are found would have the greatest impact.
- Published
- 2021
- Full Text
- View/download PDF
117. Impact of Covid-19 on health-related quality of life of patients: A structured review
- Author
-
Ak Narayan Poudel, Shihua Zhu, Nicola Cooper, Paul Roderick, Nisreen Alwan, Carolyn Tarrant, Nida Ziauddeen, and Guiqing Lily Yao
- Subjects
Medicine ,Science - Abstract
Introduction Coronavirus disease (Covid-19) has led to a global pandemic since its emergence in December 2019. The majority of research into Covid-19 has focused on transmission, and mortality and morbidity associated with the virus. However, less attention has been given to its impact on health-related quality of life (HRQoL) of patients with Covid-19. Methods We searched for original studies published between December 2019 and Jan 2021 in PubMed, Scopus and Medline databases using a specific search strategy. We also explored literature on websites of distinguished public health organisations and hand-searched reference lists of eligible studies. The studies were screened by two reviewers according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flowchart using pre-determined eligibility criteria. Data were synthesised, analysed descriptively and reported in line with PRISMA guidelines. Results In total, 1276 studies were identified through the search strategy. Of these, 77 studies were selected for full-text reading after screening the studies. After reading full-text, 12 eligible studies were included in this review. The majority of the studies used a generic HRQoL assessment tool; five studies used SF-36, five studies used EQ-5D-5L, and three used pulmonary disease-specific HRQoL tools (two studies used two tools each). The impact of Covid-19 on HRQoL was found to be considerable in both Acute Covid and Long Covid patients. Higher impact on HRQoL was reported in Acute Covid, females, older ages, patients with more severe disease and patients from low-income countries. Conclusion The impact of Covid-19 on HRQoL of Acute and Long Covid patients is substantial. There was disproportional impact on patients by gender, age, severity of illness and study country. The long-term impact of Covid-19 is still in its initial stage. The findings of the review may be useful to researchers, policymakers, and clinicians caring for people following Covid-19 infection.
- Published
- 2021
118. Automated recognition of obstructive sleep apnoea syndrome from ECG recordings.
- Author
-
Y?ld?z, A., Ak?n, M., and Poyraz, M.
- Published
- 2010
- Full Text
- View/download PDF
119. FPGA based early fault detection system.
- Author
-
Aydin, I., Karako?se, M., and Ak?n, E.
- Published
- 2010
120. Adaptive PWM control scheme of interleaved boost converter for AC traction application.
- Author
-
Tez?ak, N. and Macan, M.
- Published
- 2010
- Full Text
- View/download PDF
121. IP-0041 Are hepatitis B virus carriers at risk of coronary atherosclerosis?
- Author
-
Domanic, N., primary, Ak n, P., additional, Vural, V.A., additional, Balc, H., additional, Avasar, S., additional, Ipekci, S.H., additional, Ulutin, T., additional, and Sonmez, H., additional
- Published
- 2003
- Full Text
- View/download PDF
122. P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL
- Author
-
P Sonneveld, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, I Spicka, V Hungria, M Munder, MV Mateos, TM Mark, MD Levin, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, and A Spencer
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
123. IP-0041 Are hepatitis B virus carriers at risk of coronary atherosclerosis?
- Author
-
N. Domanic, P. Ak n, V.A. Vural, H. Balc, S. Avasar, S.H. Ipekci, T. Ulutin, and H. Sonmez
- Subjects
Hepatitis B virus ,business.industry ,Immunology ,Internal Medicine ,medicine ,General Medicine ,Cardiology and Cardiovascular Medicine ,medicine.disease_cause ,business ,Coronary atherosclerosis - Published
- 2003
- Full Text
- View/download PDF
124. Improvement in electrical performance of half-metallic Fe 3 O 4 /GaAs structures using pyrolyzed polymer film as buffer layer.
- Author
-
Ak?n, Seçkin, Özel, Faruk, Ku?, Mahmut, and Sönmezo?lu, Sava?
- Subjects
- *
ELECTRIC properties of metals , *IRON oxides , *GALLIUM arsenide , *POLYMER films , *PYROLYSIS , *BUFFER layers , *MAGNETIC nanoparticles - Abstract
In this work, the Fe3O4magnetic nanoparticles (MNPs) were synthesized by a colloidal method. TEM images reveal that Fe3O4MNPs are spherical in shape with a narrow size distribution in the range of 6–7?nm. These MNPs were used in the fabrication of two types ofn-GaAs-based structures: (i) Fe3O4/n-GaAs (reference); and (ii) Fe3O4/PPF/n-GaAs. We present that carbon-based pyrolyzed polymer films (PPFs), as a buffer layer, can control the electrical characteristics of a conventional Fe3O4/n-GaAs device. The behaviour of the apparent barrier height and ideality factor with the interfacial layer due to the presence of the interface state density is discussed. PPF raises the barrier height in a Fe3O4/PPF/n-GaAs half-metallic/insulator/semiconductor (h-MIS) device as high as 0.620.002?eV. Furthermore, Fe3O4/PPF interfaces exhibit unique electronic properties including high-quality interface, low series resistance (from 17.73?k? to 85.66??) and extremely low interface state density (1.76?×?1012?eV?1?cm?2). Compared to the electrical performance for the Fe3O4/n-GaAs junction, that for the Fe3O4/PPF/n-GaAs junction was enhanced. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
125. From Rags to Riches: Assessing poverty and vulnerability in urban Nepal.
- Author
-
Tim Ensor, Radheshyam Bhattarai, Shraddha Manandhar, Ak Narayan Poudel, Rajeev Dhungel, Sushil Baral, Joseph P Hicks, Dana Thomson, and Helen Elsey
- Subjects
Medicine ,Science - Abstract
Urbanisation brings with it rapid socio-economic change with volatile livelihoods and unstable ownership of assets. Yet, current measures of wealth are based predominantly on static livelihoods found in rural areas. We sought to assess the extent to which seven common measures of wealth appropriately capture vulnerability to poverty in urban areas. We then sought to develop a measure that captures the characteristics of one urban area in Nepal. We collected and analysed data from 1,180 households collected during a survey conducted between November 2017 and January 2018 and designed to be representative of the Kathmandu valley. A separate survey of a sub set of households was conducted using participatory qualitative methods in slum and non-slum neighbourhoods. A series of currently used indices of deprivation were calculated from questionnaire data. We used bivariate statistical methods to examine the association between each index and identify characteristics of poor and non-poor. Qualitative data was used to identify characteristics of poverty from the perspective of urban poor communities which were used to construct an Urban Poverty Index that combined asset and consumption focused context specific measures of poverty that could be proxied by easily measured indicators as assessed through multivariate modelling. We found a strong but not perfect association between each measure of poverty. There was disagreement when comparing the consumption and deprivation index on the classification of 19% of the sample. Choice of short-term monetary and longer-term capital approaches accounted for much of the difference. Those who reported migrating due to economic necessity were most likely to be categorised as poor. A combined index was developed to capture these dimension of poverty and understand urban vulnerability. A second version of the index was constructed that can be computed using a smaller range of variables to identify those in poverty. Current measures may hide important aspects of urban poverty. Those who migrate out of economic necessity are particularly vulnerable. A composite index of socioeconomic status helps to capture the complex nature of economic vulnerability.
- Published
- 2020
- Full Text
- View/download PDF
126. Surgical Treatment of Superior Sulcus Tumors: Results and Prognostic Factors.
- Author
-
Demir, A., Sayar, A., Kocaturk, C. I., Gunluoglu, M. Z., Ak�n, H., Metin, M., Cansever, L., Olcmen, A., Dincer, S. I., Bedirhan, M. A., and Gurses, A.
- Abstract
Background: This study aims to investigate the treatment modalities and factors influencing survival in surgically treated superior sulcus tumors.Patients and Method: Sixty-five cases of surgically treated non-small cell carcinoma of the lung occurring as superior sulcus tumors between 1994 and 2007 were retrospectively reviewed. Twenty-five patients underwent induction radiotherapy (RT), 10 had induction chemoradiotherapy (CT/RT). In thirty patients surgery was performed directly. The mortality rate was 6.2 %. Pathological stage was T3 in 55, T4 in 10, N0 in 52, and N1 in 5 and N2 in 8 patients.Results: Overall 5- and 10-year survival rates were 31 % and 28 %, respectively. Complete resection rate was 90 % for patients who received induction CT/RT and 80 % for patients who either received induction RT alone or patients in whom surgery was performed directly. In patients who received neoadjuvant therapy with complete tumor resection, the median survival time was 33 months (28 months for patients who received induction RT alone and 36 months for patients who received induction CT/RT), and the 5-year survival rate was 41 %. Median survival time and 5-year survival rate of patients treated by direct surgery with complete resection was 24 months and 37 %, respectively (p = 0.87). Five-year survival and 10-year survival rates were significantly higher after complete resection than after incomplete resection (38 % and 34 % vs. 0 %,p = 0.0001). In multivariate analysis, only N2 disease (p = 0.04) and incomplete resection (p = 0.03) were found to be poor prognostic factors.Conclusion: The presence of N2 disease and incomplete resection are the two most important factors affecting survival. Induction CT/RT may increase the ability to achieve complete surgical resection. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
127. Scanning tunneling microscopy of defects in NbSe2.
- Author
-
Prodan, A., Marinkovic, V., Gril, R., Ramsˇak, N., van Midden, H. J. P., Boswell, F. W., and Bennett, J. C.
- Published
- 2000
- Full Text
- View/download PDF
128. Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review
- Author
-
Wenjuan Cong, Ak Narayan Poudel, Nour Alhusein, Hexing Wang, Guiqing Yao, and Helen Lambert
- Subjects
COVID-19 patients ,disease severity ,antibiotic use ,clinical justification ,secondary infections ,Therapeutics. Pharmacology ,RM1-950 - Abstract
This scoping review provides new evidence on the prevalence and patterns of global antimicrobial use in the treatment of COVID-19 patients; identifies the most commonly used antibiotics and clinical scenarios associated with antibiotic prescribing in the first phase of the pandemic; and explores the impact of documented antibiotic prescribing on treatment outcomes in COVID-19 patients. The review complies with PRISMA guidelines for Scoping Reviews and the protocol is registered with the Open Science Framework. In the first six months of the pandemic, there was a similar mean antibiotic prescribing rate between patients with severe or critical illness (75.4%) and patients with mild or moderate illness (75.1%). The proportion of patients prescribed antibiotics without clinical justification was 51.5% vs. 41.9% for patients with mild or moderate illness and those with severe or critical illness. Comparison of patients who were provided antibiotics with a clinical justification with those who were given antibiotics without clinical justification showed lower mortality rates (9.5% vs. 13.1%), higher discharge rates (80.9% vs. 69.3%), and shorter length of hospital stay (9.3 days vs. 12.2 days). In the first 6 months of the pandemic, antibiotics were prescribed for COVID-19 patients regardless of severity of illness. A large proportion of antibiotic prescribing for mild and moderate COVID-19 patients did not have clinical evidence of a bacterial co-infection. Antibiotics may not be beneficial to COVID-19 patients without clinical evidence of a bacterial co-infection.
- Published
- 2021
- Full Text
- View/download PDF
129. Plasma channel localisation during multiple filamentation in air
- Author
-
Panov, N A, Kosareva, O G, Kandidov, V P, Ak, N, Scalora, M, and Chin, S L
- Abstract
It is shown by numerical simulations that multiple filamentation of a femtosecond laser pulse with a negative initial phase modulation in air leads to an increase in the density of self-induced laser plasma compared to the case when a transform-limited laser pulse of the same duration is used. Simultaneous control of the duration of the chirped pulse and the beam diameter results in an increase in the distance over which the first filament is formed, the length of the plasma channel, and its linear density.
- Published
- 2007
130. Effect of frequency of collection on seminal characteristics of White Pekin duck
- Author
-
AK Nahak, SC Giri, DN Mohanty, PC Mishra, and SK Dash
- Subjects
White Pekin duck ,Semen collection interval ,Artificial insemination ,Medicine - Abstract
Objective: To determine an optimum frequency of semen collection, so as to improve the efficacy of artificial insemination techniques and selective breeding programmes in duck farming. Methods: Thirty two ejaculates were collected by abdominal massage method from two groups of drakes, with 10 in each, at one day and two day intervals respectively. Routine seminal attributes such as volume, colour, pH, spermatozoa concentration, number of spermatozoa per ejaculate, individual motility, live sperm percentage, total sperm abnormalities and time taken to reduce Methylene blue (MBRT) were studied for comparison of their values in one day and two days of interval of semen collection. Twenty female laying ducks maintained for examining the fertility percent were regularly inseminated with 0.1 mL of neat pooled semen for fertility test. Results: The test of significance indicated a significant decrease (P
- Published
- 2015
- Full Text
- View/download PDF
131. Effect of seasons on semen production, effect of melatonin on the liquid storage (5 °C) with correlated study of birth rate in mithun (Bos frontalis)
- Author
-
P Perumal, JK Chamuah, AK Nahak, and C Rajkhowa
- Subjects
melatonin (MT) ,Mithun ,Seminal parameters ,Antioxidant profiles ,Biochemical parameters ,Breeding seasons ,Calf birth rate ,Medicine - Abstract
Objective: To assess the effect of melatonin (MT) at different seasons of the year on sperm motility, viability, total sperm abnormality, acrosomal membrane, plasma membrane and nuclear integrity, antioxidant profiles such as superoxide dismutase (SOD), catalase (CAT), glutathione (GSH) and total antioxidant capacity (TAC), enzymatic profiles such as aspartate amino transaminase (AST), alanine amino transaminase (ALT) and biochemical profiles such as malondialdehyde (MDA) production. Methods: Total numbers of 80 ejaculates (20 ejaculates in each season) were collected twice a week from mithun bulls and semen was split into five equal aliquots, diluted with the tris egg yolk citrate (TEYC) extender. Group 1: semen without additives (control), group 2 to group 5: semen was diluted with 1 mM, 2 mM, 3 mM, and 4 mM of melatonin, respectively. These seminal parameters, antioxidant, enzymatic and biochemical profiles were assessed at liquid storage of mithun semen (5 °C). Simultaneously, retrospective study was conducted on birth rate of calf at different seasons from 2002 to 2012 from farm birth register of mithun farm. Results: Inclusion of melatonin into diluent resulted in significant (P
- Published
- 2015
- Full Text
- View/download PDF
132. Transverse momentum spectra of charged particles in proton–proton collisions at s=900 GeV with ALICE at the LHC
- Author
-
Aamodt, By, K., Abel, Aq, N., Abeysekara, Bw, U., Abrahantes, Quintana, Ap, A., Abramyan, Dh, A., Adamová, Cg, D., Aggarwal, M. M. y., Aglieri, Rinella, An, G., Agocs, A. G. r., Aguilar, Salazar, Bk, S., Ahammed, Ba, Z., Ahmad, A. b., Ahmad, N. b., Ahn, S. U., Al, Akimoto, Cu, R., Akindinov, Bn, A., Aleksandrov, Bp, D., Alessandro, Cz, B., Alfaro, Molina, Bk, R., Alici, A. m., Almaráz, Aviña, Bk, E., Alme, J. h., Alt, Aq, T., Altini, V. e., Altinpinar, Ae, S., Andrei, C. q., Andronic, Ae, A., Anelli, Angelov, Aq, V., Anson, Aa, C., Antičić, Di, T., Antinori, An, F., Antinori, S. m., Antipin, Aj, K., Antończyk, Aj, D., Antonioli, P. n., Anzo, Bk, A., Aphecetche, Bs, L., Appelshäuser, Aj, H., Arcelli, S. m., Arceo, Arend, Aj, A., Armesto, Cm, N., Arnaldi, Cz, R., Aronsson, Bt, T., Arsene, I. C., By, Asryan, Cs, A., Augustinus, An, A., Averbeck, Ae, R., Awes, T. C., Bv, Äystö, Aw, J., Azmi, M. D. b., Bablok, S. h., Bach, Ai, M., Badalà, A. x., Baek, Y. W., Al, Bagnasco, Cz, S., Bailhache, Bala, Cy, R., Baldisseri, Cj, A., Baldit, A. z., Bán, Bd, J., Barbera, R. w., Barnaföldi, G. G. r., Barnby, L. l., Barret, V. z., Bartke, Ac, J., Barile, F. e., Basile, M. m., Basmanov, Co, V., Bastid, N. z., Bathen, Br, B., Batigne, Bs, G., Batyunya, Ah, B., Baumann, Br, C., Bearden, I. G., Ab, Becker, B. t., Belikov, Ct, I., Bellwied, Ag, R., Belmont, Moreno, Belogianni, A. d., Benhabib, Beole, Cy, S., Berceanu, I. q., Bercuci, Berdermann, Ae, E., Berdnikov, Am, Y., Betev, An, L., Bhasin, Av, A., Bhati, A. K. y., Bianchi, Cy, L., Ak, N., Bianchin, Bz, C., Bielčík, Cb, J., Bielčíková, Cg, J., Bilandzic, A. c., Bimbot, Bx, L., Biolcati, Cy, E., Blanc, A. z., Blanco, F. w., Blanco, Bi, F., Blau, Blume, Aj, C., Boccioli, An, M., Bock, Aa, N., Bogdanov, Bo, A., Bøggild, Ab, H., Bogolyubsky, Cd, M., Bohm, Cq, J., Boldizsár, L. r., Bombara, Bc, M., Bombonati, Bondila, Aw, M., Borel, Cj, H., Borisov, Ax, A., Bortolin, Bose, Az, S., Bosisio, Luciano, Bossú, Cy, F., Botje, M. c., Böttger, Aq, S., Bourdaud, Boyer, Bx, B., Braun, Cs, M., Braun, Munzinger, ae af, P., Bravina, By, L., Bregant, Marco, Breitner, Bruckner, Brun, An, R., Bruna, Bt, E., Bruno, G. E. e., Budnikov, Co, D., Buesching, Buncic, An, P., Busch, Ar, O., Buthelezi, Z. v., Caffarri, Bz, D., Cai, Dg, X., Caines, Bt, H., Calvo, Bf, E., Camacho, Bl, E., Camerini, Paolo, Campbell, Canoa, Roman, An, V., Capitani, G. P., Ak, Cara, Romeo, G. n., Carena, Carena, An, W., Carminati, Casanova, Díaz, Ak, A., Caselle, Castillo, Castellanos, Cj, J., Castillo, Hernandez, J. F., Ae, Catanescu, V. q., Cattaruzza, Enrico, Cavicchioli, An, C., Cerello, Cz, P., Chambert, Bx, V., Chang, Cq, B., Chapeland, An, S., Charpy, Bx, A., Charvet, J. L., Cj, Chattopadhyay, Ba, S., Cherney, Bw, M., Cheshkov, Cheynis, Db, B., Chiavassa, Chibante, Barroso, Chinellato, D. D. u., Chochula, Choi, Cf, K., Chojnacki, Da, M., Christakoglou, Da, P., Christensen, C. H., Ab, Christiansen, Bh, P., Chujo, Cx, T., Chuman, As, F., Cicalo, C. t., Cifarelli, L. m., Cindolo, F. n., Cleymans, J. v., Cobanoglu, Cy, O., Coffin, J. P., Ct, Coli, Colla, Conesa, Balbastre, Ak, G., Conesa del Valle, Bs, Z., Conner, E. S., Df, Constantin, Ar, P., Contin, Giacomo, Contreras, J. G., Bl, Corrales, Morales, Cy, Y., Cormier, T. M., Ag, Cortese, P. a., Cortés, Maldonado, Ce, I., Cosentino, M. R. u., Costa, Cotallo, M. E., Bi, Crescio, Crochet, P. z., Cuautle, Bj, E., Cunqueiro, Ak, L., Cussonneau, Bs, J., Dainese, Ca, A., Dalsgaard, H. H., Ab, Danu, A. p., Das, Az, I., Dash, A. k., Dash, S. k., Barros, De, G. O. V., Cn, Caro, De, Ck, A., Cataldo, De, G. f., Cuveland, De, Aq, J., Falco, De, A. s., Gaspari, De, Ar, M., Groot, De, An, J., Gruttola, De, Ck, D., Marco, De, Cz, N., Pasquale, De, Ck, S., Remigis, De, Rooij, De, Da, R., Vaux, De, G. v., Delagrange, Bs, H., Delgado, Bf, Y., Dellacasa, G. a., Deloff, Dc, A., Demanov, Dénes, E. r., Deppman, Cn, A., D'Erasmo, G. e., Derkach, Cs, D., Devaux, A. z., Bari, Di, D. e., Giglio, Di, C. e., Liberto, Di, Ci, S., Mauro, Di, Nezza, Di, Ak, P., Dialinas, Bs, M., Díaz, Bj, L., Aw, R., Dietel, Br, T., Divià, Djuvsland, Ø. h., Dobretsov, Bp, V., Dobrin, Bh, A., Dobrowolski, Dc, T., Dönigus, Ae, B., Domínguez, Bj, I., Don, D. M. M., At, Dordic, By, O., Dubey, A. K., Ba, Dubuisson, Ducroux, Db, L., Dupieux, P. z., Dutta, Majumdar, A. K., Az, M. R., Ba, Elia, D. f., Emschermann, Ar, D., Enokizono, Bv, A., Espagnon, Estienne, Esumi, Cx, S., Evans, D. l., Evrard, Eyyubova, By, G., Fabjan, C. W., An, Fabris, Ca, D., Faivre, Ao, J., Falchieri, D. m., Fantoni, Fasel, Ae, M., Fateev, Ah, O., Fearick, R. v., Fedunov, Ah, A., Fehlker, D. h., Fekete, V. o., Felea, D. p., Fenton, Olsen, Ab, B., Feofilov, Cs, G., Fernández, Téllez, Ce, A., Ferreiro, E. G., Cm, Ferretti, Cy, A., Ferretti, R. a., Figueredo, M. A. S., Cn, Filchagin, Co, S., Fini, R. f., Fionda, F. M. e., Fiore, E. M. e., Floris, M. s., Fodor, Z. r., Foertsch, S. v., Foka, Ae, P., Fokin, Bp, S., Formenti, Fragiacomo, Enrico, Fragkiadakis, M. d., Frankenfeld, Ae, U., Frolov, Bu, A., Fuchs, An, U., Furano, Furget, Ao, C., Fusco, Girard, Ck, M., Gaardhøje, J. J., Ab, Gadrat, Ao, S., Gagliardi, Cy, M., Gago, Bf, A., Gallio, Ganoti, P. d., Ganti, M. S., Ba, Garabatos, Ae, C., García, Trapaga, Cy, C., Gebelein, Gemme, R. a., Germain, Gheata, Ghidini, B. e., Ghosh, Ba, P., Giraudo, Cz, G., Giubellino, Gladysz, Dziadus, Ac, E., Glasow, Br, R., Glässel, Glenn, Bg, A., Gómez, Jiménez, Ad, R., González, Santos, Ce, H., González, Trueba, L. H., Bk, González, Zamora, Bi, P., Gorbunov, Bw, Y., Gotovac, Cr, S., Gottschlag, Br, H., Grabski, Bk, V., Grajcarek, Ar, R., Grelli, Da, A., Grigoras, Grigoriev, Bo, V., Grigoryan, Ah, S., Grinyov, Ax, B., Grion, Cw, N., Gros, Grosse, Oetringhaus, J. F., An, Grossiord, J. Y., Db, Grosso, Raffaele, Guber, Bm, F., Guernane, Ao, R., Guerra, Bf, C., Guerzoni, B. m., Gulbrandsen, Ab, K., Gulkanyan, Dh, H., Gunji, Cu, T., Gupta, Av, R., Gustafsson, H. A., Bh, Gutbrod, Ae, H., Haaland, Ø. h., Hadjidakis, Bx, C., Haiduc, M. p., Hamagaki, Cu, H., Hamar, G. r., Hamblen, Ay, J., Han, B. H., Cp, Harris, J. W., Bt, Hartig, Aj, M., Harutyunyan, Hasch, Ak, D., Hasegan, D. p., Hatzifotiadou, D. n., Hayrapetyan, Heide, Br, M., Heinz, Bt, M., Helstrup, H. i., Herghelegiu, A. q., Hernández, Herrera, Corral, Bl, G., Herrmann, Ar, N., Hetland, K. F. i., Hicks, Bt, B., Hiei, As, A., Hille, P. T., By, Hippolyte, Ct, B., Horaguchi, As, T., Hori, Cu, Y., Hristov, Hřivnáčová, Bx, I., S. g., Hu, Huang, M. h., Huber, Humanic, T. J., Aa, Hutter, Ai, D., Hwang, D. S., Cp, Ichou, Bs, R., Ilkaev, Co, R., Ilkiv, Dc, I., Inaba, Cx, M., Innocenti, P. G., An, Ippolitov, Bp, M., Irfan, M. b., Ivan, Da, C., Ivanov, Am, V., Iwasaki, Jachołkowski, Jacobs, P. j., Jančurová, Ah, L., Jangal, Ct, S., Janik, R. o., Jena, C. k., Jena, Bq, S., Jirden, Jones, G. T. l., Jones, P. G. l., Jovanović, P. l., Jung, Al, H., Al, W., Jusko, A. l., Kaidalov, A. B., Bn, Kalcher, Kalićák, Bd, P., Kalisky, Kalliokoski, Aw, T., Kalweit, Af, A., Kamal, A. b., Kamermans, Kanaki, K. h., Kang, Al, E., J. H., Cq, Kapitan, Kaplin, Kapusta, Karavichev, Bm, O., Karavicheva, Bm, T., Karpechev, Bm, E., Kazantsev, Bp, A., Kebschull, Aq, U., Keidel, Df, R., Khan, M. M. b., Khan, S. A., Ba, Khanzadeev, Am, A., Kharlov, Cd, Y., Kikola, Dd, D., Kileng, B. i., Kim, D. J., Aw, D. S., Al, D. W., Al, H. N., Al, Cd, J., J. H., Cp, J. S., Al, Al, M., Cq, M., S. H., Al, Cp, S., Cq, Y., Kirsch, Kisel, Aq, I., Kiselev, Bn, S., Kisiel, Aa, A., Klay, J. L., Cl, Klein, Ar, J., Klein, Bösing, Kliemant, Klovning, A. h., Kluge, Knichel, M. L., Ae, Kniege, Aj, S., Koch, Ar, K., Kolevatov, By, R., Kolojvari, Kondratiev, Cs, V., Kondratyeva, Bo, N., Konevskih, Bm, A., Kornać, Kour, R. l., Kowalski, Ac, M., Kox, Kozlov, Bp, K., Kral, Králik, Bd, I., Kramer, Aj, F., Kraus, Af, I., Kravćáková, Bc, A., Krawutschke, Bb, T., Krivda, M. l., Krumbhorn, Krus, Cb, M., Kryshen, Am, E., Krzewicki, M. c., Kucheriaev, Bp, Y., Kuhn, Ct, C., Kuijer, P. G. c., Kumar, L. y., Kumar, N. y., Kupczak, Dd, R., Kurashvili, Dc, P., Kurepin, A. N., Bm, Kuryakin, Co, A., Kushpil, Cg, S., Cg, V., Kutouski, Ah, M., Kvaerno, By, H., Kweon, M. J., Ar, Kwon, Rocca, La, P. w., Lackner, Ladrón de Guevara, Lafage, Lal, Av, C., Lara, Aq, C., Larsen, D. T. h., Laurenti, G. n., Lazzeroni, C. l., Bornec, Le, Bx, Y., Bris, Le, Bs, N., Lee, Cf, H., K. S., Al, S. C., Al, Lefèvre, Bs, F., Lenhardt, Leistam, Lehnert, Aj, J., Lenti, V. f., León, Bk, H., León, Monzón, Ad, I., León, Vargas, Lévai, P. r., X. g., Li, Y. g., Li, Lietava, R. l., Lindal, By, S., Lindenstruth, Lippmann, Lisa, M. A., Aa, Liu, L. h., Loginov, Lohn, Lopez, X. z., López, Noriega, Bx, M., López, Ramírez, Ce, R., López, Torres, Ap, E., Løvhøiden, Lozea Feijo Soares, S. g., Lu, Luettig, Aj, P., Lunardon, Bz, M., Luparello, Cy, G., Luquin, Lutz, J. R., Ct, Dg, K., Bt, R., Madagodahettige, Don, D. M., At, Maevskaya, Mager, Af, M., Mahapatra, D. P. k., Maire, Ct, A., Makhlyueva, An, I., Mal'Kevich, Bn, D., Malaev, Am, M., Malagalage, K. J., Bw, Maldonado, Cervantes, Malek, Malkiewicz, Malzacher, Mamonov, Manceau, L. z., Mangotra, Av, L., Manko, Manso, F. z., Manzari, V. f., Mao, Dg, Y., Mareš, Cc, J., Margagliotti, Giacomo, Margotti, A. n., Marín, Martashvili, Ay, I., Martinengo, Martínez, Hernández, M. I., Ce, Martínez, Davalos, Martínez, García, Maruyama, As, Y., Marzari, Chiesa, Masciocchi, Masera, Masetti, M. m., Masoni, A. t., Massacrier, Mastromarco, M. f., Mastroserio, A. e., Matthews, Z. L. l., Matyja, Ac, A., Mayani, Bj, D., Mazza, Mazzoni, M. A., Ci, Meddi, Ch, F., Menchaca, Rocha, Mendez, Lorenzo, Meoni, Mercado, Pérez, Mereu, Miake, Cx, Y., Michalon, Miftakhov, Am, N., Milano, Milosevic, By, J., Minafra, F. e., Mischke, Mićkowiec, Ae, D., Mitu, C. p., Mizoguchi, As, K., Mlynarz, Ag, J., Mohanty, Ba, B., Molnar, L. r., Mondal, M. M., Ba, Montaño, Zetina, Bl, L., Monteno, Cz, M., Montes, Bi, E., Morando, Moretto, Bz, S., Morsch, Moukhanova, Bp, T., Muccifora, Ak, V., Mudnic, Cr, E., Muhuri, Müller, An, H., Munhoz, M. G., Cn, Munoz, Ce, J., Musa, Musso, Cz, A., Nandi, B. K., Bq, Nania, R. n., Nappi, E. f., Navach, F. e., Navin, S. l., Nayak, T. K., Ba, Nazarenko, Nazarov, Co, G., Nedosekin, Nendaz, Db, F., Newby, Bg, J., Nianine, Nicassio, M. f., Nielsen, B. S., Ab, Nikolaev, Nikolic, Di, V., Nikulin, Nilsen, B. S., Bw, Nilsson, M. S., By, Noferini, F. n., Nomokonov, Ah, P., Nooren, Da, G., Novitzky, Aw, N., Nyatha, Bq, A., Nygaard, Ab, C., Nyiri, By, A., Nystrand, J. h., Ochirov, Odyniec, G. j., Oeschler, Af, H., Oinonen, Okada, Cu, K., Oldenburg, Oleniacz, Dd, J., Oppedisano, Cz, C., Orsini, Cj, F., Ortiz, Velasquez, Bj, A., Ortona, Oskarsson, Osmic, Österman, Bh, L., Ostrowski, Dd, P., Otterlund, Bh, I., Otwinowski, Ae, J., Øvrebekk, G. h., Oyama, Ozawa, Pachmayer, Ar, Y., Pachr, Padilla, Pagano, Ck, P., Paić, Bj, G., Painke, Aq, F., Pajares, Cm, C., Pal, S. K., Ba, Palaha, A. l., Palmeri, A. x., Panse, Aq, R., Papikyan, Dh, V., Pappalardo, G. S. x., Park, W. J., Ae, Pastirćák, Bd, B., Pastore, C. f., Paticchio, V. f., Pavlinov, Ag, A., Pawlak, Dd, T., Peitzmann, Da, T., Pepato, Pereira, Peressounko, Pérez, Perini, An, D., Perrino, D. e., Peryt, Dd, W., Peschek, Pesci, A. n., Peskov, Bj, V., Pestov, Bu, Y., Peters, A. J., An, Petráćek, Cb, V., Petridis, A. d., Petris, M. q., Petrov, P. l., Petrovici, M. q., Petta, C. w., Peyré, Bx, J., Piano, Stefano, Piccotti, Pikna, M. o., Pillot, Bs, P., Pinazza, O. n., Pinsky, At, L., Pitz, Aj, N., Piuz, Platt, R. l., Pćoskoć, M. j., Pluta, Pocheptsov, Ah, T., Pochybova, S. r., Podesta, Lerma, P. L. M., Ad, Poggio, Poghosyan, M. G., Cy, Polák, Cc, K., Polichtchouk, Cd, B., Polozov, Bn, P., Polyakov, Pommeresch, B. h., Pop, A. q., Posa, F. e., Pospíšil, Potukuchi, Av, B., Pouthas, Prasad, Preghenella, R. m., Prino, Cz, F., Pruneau, C. A., Ag, Pshenichnov, Bm, I., Puddu, G. s., Pujahari, Bq, P., Pulvirenti, A. w., Punin, Putiš, Putschke, Bt, J., Quercigh, An, E., Rachevski, Cw, A., Rademakers, Radomski, Ar, S., Räihä, T. S., Aw, Rak, Rakotozafindrabe, Ramello, L. a., Ramírez, Reyes, Bl, A., Rammler, Raniwala, Au, R., Au, S., Räsänen, S. S., Aw, Rashevskaya, Cw, I., Rath, S. k., Read, K. F., Ay, Real, J. S., Ao, Redlich, Dc, K., Renfordt, Aj, R., Reolon, A. R., Ak, Reshetin, Rettig, Revol, J. P., An, Reygers, Br, K., Ricaud, Riccati, Cz, L., Ricci, R. A., Be, Richter, M. h., Riedler, Riegler, Riggi, F. w., Rivetti, Rodriguez, Cahuantzi, Ce, M., Røed, K. i., Röhrich, Román, López, Ce, S., Romita, R. e., Ronchetti, Ak, F., Rosinskỳ, Rosnet, P. z., Rossegger, Rossi, Cv, A., Roukoutakis, Rousseau, Bx, S., Roy, Bs, C., Az, P., Rubio, Montero, A. J., Bi, Rui, Rinaldo, Rusanov, Ar, I., Russo, Ck, G., Ryabinkin, Bp, E., Rybicki, Sadovsky, Cd, S., Šafaćík, An, K., Sahoo, Bz, R., Saini, Ba, J., Saiz, Sakata, Cx, D., Salgado, C. A., Cm, Salgueiro Domingues da Silva, Salur, S. j., Samanta, Ba, T., Sambyal, Av, S., Samsonov, Šándor, Bd, L., Sandoval, Sano, Cu, S., Santo, Santoro, R. e., Sarkamo, Saturnini, P. z., Scapparone, E. n., Scarlassara, Bz, F., Scharenberg, R. P., De, Schiaua, C. q., Schicker, Schindler, Schmidt, H. R., Ae, Schossmaier, Schreiner, Schuchmann, Schukraft, Schutz, Bs, Y., Schwarz, Ae, K., Schweda, Scioli, G. m., Scomparin, Cz, E., Scott, P. A. l., Segato, Bz, G., Semenov, Senyukov, S. a., Seo, Al, J., Serci, S. s., Serkin, Serradilla, Sevcenco, A. p., Sgura, I. e., Shabratova, Ah, G., Shahoyan, Sharkov, Bn, G., Sharma, N. y., Sharma, Shigaki, Shimomura, Shtejer, Ap, K., Sibiriak, Siciliano, Sicking, Siddi, E. t., Siemiarczuk, Silenzi, A. m., Silvermyr, Bv, D., Simili, Da, E., Simonetti, G. e., Singaraju, Ba, R., Singh, Singhal, Ba, V., Sinha, B. C., Ba, Az, T., Sitar, B. o., Sitta, M. a., Skaali, T. B., By, Skjerdal, K. h., Smakal, Cb, R., Smirnov, Bt, N., Snellings, R. c., Snow, H. l., Søgaard, Soloviev, Cd, A., Soltveit, H. K., Ar, Soltz, Bg, R., Sommer, Aj, W., Son, C. W., Cf, Cp, H., Song, Soos, Soramel, Soyk, Spyropoulou, Stassinaki, M. d., Srivastava, B. K., De, Stachel, Staley, Stan, E. p., Stefanek, Dc, G., Stefanini, Steinbeck, Stenlund, Bh, E., Steyn, G. v., Stocco, Cy, D., Stock, Stolpovsky, Cd, P., Strmen, P. o., Suaide, A. A. P., Cn, Subieta, Vásquez, M. A., Cy, Sugitate, Suire, Šumbera, Cg, M., Susa, Swoboda, Symons, J. j., Szanto de Toledo, Szarka, I. o., Szostak, A. t., Szuba, Dd, M., Tadel, Tagridis, C. d., Takahara, Cu, A., Takahashi, J. u., Tanabe, Cx, R., Tapia, Takaki, J. D., Bx, Taureg, Tauro, Tavlet, Tejeda, Muñoz, Ce, G., Telesca, Terrevoli, C. e., Thäder, Tieulent, Db, R., Tlusty, Cb, D., Toia, Tolyhy, T. r., Torcato de Matos, Torii, As, H., Torralba, Aq, G., Toscano, Tosello, Tournaire, Bs, A., Traczyk, Tribedy, Tröger, Truesdale, Aa, D., Trzaska, W. H., Aw, Tsiledakis, Ar, G., Tsilis, E. d., Tsuji, Tumkin, Turrisi, Ca, R., Turvey, Bw, A., Tveter, T. S., By, Tydesjö, Tywoniuk, Ulery, Ullaland, K. h., Uras, A. s., Urbán, Bc, J., Urciuoli, G. M., Ci, Usai, G. L. s., Vacchi, Vala, Valencia, Palomo, Bk, L., Vallero, van der Kolk, N. c., Vande, Vyvre, Van, Leeuwen, Vannucci, Be, L., Vargas, Varma, Bq, R., Vasiliev, Vassiliev, Vasileiou, M. d., Vechernin, Venaruzzo, Massimo, Vercellin, Vergara, Vernet, R. w., Verweij, Vetlitskiy, Bn, I., Vickovic, Cr, L., Viesti, Vikhlyantsev, Co, O., Vilakazi, Z. v., Villalobos, Baillie, O. l., Vinogradov, Vinogradov, Cs, L., Co, Y., Virgili, Ck, T., Viyogi, Y. P., Ba, Vodopianov, Voloshin, Bn, K., Ag, S., Volpe, G. e., Von, Haller, An, B., Vranic, Vrláková, Vulpescu, B. z., Wagner, B. h., Wagner, Wallet, Wan, Dg, R., Wang, Dg, D., Watanabe, Cx, K., Wen, Q. g., Wessels, Br, J., Westerhoff, Br, U., Wiechula, Wikne, Wilk, Br, A., Williams, M. C. S. n., Willis, Bx, N., Windelband, Ar, B., Dg, C., Yang, Ar, H., Yasnopolskiy, Yermia, Cf, J., Yin, Dg, Z., Yokoyama, Cx, H., Yoo, I. K., Cf, Yuan, Yurevich, Ah, V., Yushmanov, Bp, I., Zabrodin, By, E., Zagreev, Bn, B., Zalite, Zampolli, Zanevsky, Ah, Y., Zaporozhets, Zarochentsev, Závada, Cc, P., Zbroszczyk, Dd, H., Zelnicek, Aq, P., Zenin, Zepeda, Zgura, I. p., Zhalov, Zhang, Zhou, Zhou, S. g., Zhu, Dg, J., Zichichi, A. m., Zinchenko, Zinovjev, Ax, G., Zoccarato, Db, Y., Zycháćek, Zynovyev, M., Aamodt, K., By, Abel, N., Aq, Abeysekara, U., Bw, Abrahantes, Quintana, A., Ap, Abramyan, A., Dh, Adamová, D., Cg, Aggarwal, M. M. y., Aglieri, Rinella, G., An, Agocs, A. G. r., Aguilar, Salazar, S., Bk, Ahammed, Z., Ba, Ahmad, A. b., Ahmad, N. b., Ahn, S. U., Al, Akimoto, R., Cu, Akindinov, A., Bn, Aleksandrov, D., Bp, Alessandro, B., Cz, Alfaro, Molina, R., Bk, Alici, A. m., Almaráz, Aviña, E., Bk, Alme, J. h., Alt, T., Aq, Altini, V. e., Altinpinar, S., Ae, Andrei, C. q., Andronic, A., Ae, Anelli, Angelov, V., Aq, Anson, C., Aa, Antičić, T., Di, Antinori, F., An, Antinori, S. m., Antipin, K., Aj, Antończyk, D., Aj, Antonioli, P. n., Anzo, A., Bk, Aphecetche, L., B, Appelshäuser, H., Aj, Arcelli, S. m., Arceo, Arend, A., Aj, Armesto, N., Cm, Arnaldi, R., Cz, Aronsson, T., Bt, Arsene, I. C., By, Asryan, A., C, Augustinus, A., An, Averbeck, R., Ae, Awes, T. C., Bv, Äystö, J., Aw, Azmi, M. D. b., Bablok, S. h., Bach, M., Ai, Badalà, A. x., Baek, Y. W., Al, Bagnasco, S., Cz, Bailhache, Bala, R., Cy, Baldisseri, A., Cj, Baldit, A. z., Bán, J., Bd, Barbera, R. w., Barnaföldi, G. G. r., Barnby, L. l., Barret, V. z., Bartke, J., Ac, Barile, F. e., Basile, M. m., Basmanov, V., Co, Bastid, N. z., Bathen, B., Br, Batigne, G., B, Batyunya, B., Ah, Baumann, C., Br, Bearden, I. G., Ab, Becker, B. t., Belikov, I., Ct, Bellwied, R., Ag, Belmont, Moreno, Belogianni, A. d., Benhabib, Beole, S., Cy, Berceanu, I. q., Bercuci, Berdermann, E., Ae, Berdnikov, Y., Am, Betev, L., An, Bhasin, A., Av, Bhati, A. K. y., Bianchi, L., Cy, N., Ak, Bianchin, C., Bz, Bielčík, J., Cb, Bielčíková, J., Cg, Bilandzic, A. c., Bimbot, L., Bx, Biolcati, E., Cy, Blanc, A. z., Blanco, F. w., Blanco, F., Bi, Blau, Blume, C., Aj, Boccioli, M., An, Bock, N., Aa, Bogdanov, A., Bo, Bøggild, H., Ab, Bogolyubsky, M., Cd, Bohm, J., Cq, Boldizsár, L. r., Bombara, M., Bc, Bombonati, Bondila, M., Aw, Borel, H., Cj, Borisov, A., Ax, Bortolin, Bose, S., Az, Bosisio, Luciano, Bossú, F., Cy, Botje, M. c., Böttger, S., Aq, Bourdaud, Boyer, B., Bx, Braun, M., C, Braun, Munzinger, P., ae af, Bravina, L., By, Bregant, Marco, Breitner, Bruckner, Brun, R., An, Bruna, E., Bt, Bruno, G. E. e., Budnikov, D., Co, Buesching, Buncic, P., An, Busch, O., Ar, Buthelezi, Z. v., Caffarri, D., Bz, Cai, X., Dg, Caines, H., Bt, Calvo, E., Bf, Camacho, E., Bl, Camerini, Paolo, Campbell, Canoa, Roman, V., An, Capitani, G. P., Ak, Cara, Romeo, G. n., Carena, Carena, W., An, Carminati, Casanova, Díaz, A., Ak, Caselle, Castillo, Castellano, J., Cj, Castillo, Hernandez, J. F., Ae, Catanescu, V. q., Cattaruzza, Enrico, Cavicchioli, C., An, Cerello, P., Cz, Chambert, V., Bx, Chang, B., Cq, Chapeland, S., An, Charpy, A., Bx, Charvet, J. L., Cj, Chattopadhyay, S., Ba, Cherney, M., Bw, Cheshkov, Cheynis, B., Db, Chiavassa, Chibante, Barroso, Chinellato, D. D. u., Chochula, Choi, K., Cf, Chojnacki, M., Da, Christakoglou, P., Da, Christensen, C. H., Ab, Christiansen, P., Bh, Chujo, T., Cx, Chuman, F., A, Cicalo, C. t., Cifarelli, L. m., Cindolo, F. n., Cleymans, J. v., Cobanoglu, O., Cy, Coffin, J. P., Ct, Coli, Colla, Conesa, Balbastre, G., Ak, Conesa del, Valle, Z., B, Conner, E. S., Df, Constantin, P., Ar, Contin, Giacomo, Contreras, J. G., Bl, Corrales, Morale, Y., Cy, Cormier, T. M., Ag, Cortese, P. a., Cortés, Maldonado, I., Ce, Cosentino, M. R. u., Costa, Cotallo, M. E., Bi, Crescio, Crochet, P. z., Cuautle, E., Bj, Cunqueiro, L., Ak, Cussonneau, J., B, Dainese, A., Ca, Dalsgaard, H. H., Ab, Danu, A. p., Das, I., Az, Dash, A. k., Dash, S. k., De, Barro, G. O. V., Cn, De, Caro, A., Ck, De, Cataldo, G., F., De, Cuveland, J., Aq, De, Falco, A., S., De, Gaspari, M., Ar, De, Groot, J., An, De, Gruttola, D., Ck, De, Marco, N., Cz, De, Pasquale, S., Ck, De, Remigi, De, Rooij, R., Da, De, Vaux, G. v., Delagrange, H., B, Delgado, Y., Bf, Dellacasa, G. a., Deloff, A., Dc, Demanov, Dénes, E. r., Deppman, A., Cn, D'Erasmo, G. e., Derkach, D., C, Devaux, A. z., Di, Bari, D., E., Di, Giglio, C., E., Di, Liberto, S., Ci, Di, Mauro, Di, Nezza, P., Ak, Dialinas, M., B, Díaz, L., Bj, R., Aw, Dietel, T., Br, Divià, Djuvsland, Ø. h., Dobretsov, V., Bp, Dobrin, A., Bh, Dobrowolski, T., Dc, Dönigus, B., Ae, Domínguez, I., Bj, Don, D. M. M., At, Dordic, O., By, Dubey, A. K., Ba, Dubuisson, Ducroux, L., Db, Dupieux, P. z., Dutta, Majumdar, A. K., Az, M. R., Ba, Elia, D. f., Emschermann, D., Ar, Enokizono, A., Bv, Espagnon, Estienne, Esumi, S., Cx, Evans, D. l., Evrard, Eyyubova, G., By, Fabjan, C. W., An, Fabris, D., Ca, Faivre, J., Ao, Falchieri, D. m., Fantoni, Fasel, M., Ae, Fateev, O., Ah, Fearick, R. v., Fedunov, A., Ah, Fehlker, D. h., Fekete, V. o., Felea, D. p., Fenton, Olsen, B., Ab, Feofilov, G., C, Fernández, Téllez, A., Ce, Ferreiro, E. G., Cm, Ferretti, A., Cy, Ferretti, R. a., Figueredo, M. A. S., Cn, Filchagin, S., Co, Fini, R. f., Fionda, F. M. e., Fiore, E. M. e., Floris, M. s., Fodor, Z. r., Foertsch, S. v., Foka, P., Ae, Fokin, S., Bp, Formenti, Fragiacomo, Enrico, Fragkiadakis, M. d., Frankenfeld, U., Ae, Frolov, A., Bu, Fuchs, U., An, Furano, Furget, C., Ao, Fusco, Girard, M., Ck, Gaardhøje, J. J., Ab, Gadrat, S., Ao, Gagliardi, M., Cy, Gago, A., Bf, Gallio, Ganoti, P. d., Ganti, M. S., Ba, Garabatos, C., Ae, García, Trapaga, C., Cy, Gebelein, Gemme, R. a., Germain, Gheata, Ghidini, B. e., Ghosh, P., Ba, Giraudo, G., Cz, Giubellino, Gladysz, Dziadu, E., Ac, Glasow, R., Br, Glässel, Glenn, A., Bg, Gómez, Jiménez, R., Ad, González, Santo, H., Ce, González, Trueba, L. H., Bk, González, Zamora, P., Bi, Gorbunov, Y., Bw, Gotovac, S., Cr, Gottschlag, H., Br, Grabski, V., Bk, Grajcarek, R., Ar, Grelli, A., Da, Grigoras, Grigoriev, V., Bo, Grigoryan, S., Ah, Grinyov, B., Ax, Grion, N., Cw, Gros, Grosse, Oetringhau, J. F., An, Grossiord, J. Y., Db, Grosso, Raffaele, Guber, F., Bm, Guernane, R., Ao, Guerra, C., Bf, Guerzoni, B. m., Gulbrandsen, K., Ab, Gulkanyan, H., Dh, Gunji, T., Cu, Gupta, R., Av, Gustafsson, H. A., Bh, Gutbrod, H., Ae, Haaland, Ø. h., Hadjidakis, C., Bx, Haiduc, M. p., Hamagaki, H., Cu, Hamar, G. r., Hamblen, J., Ay, Han, B. H., Cp, Harris, J. W., Bt, Hartig, M., Aj, Harutyunyan, Hasch, D., Ak, Hasegan, D. p., Hatzifotiadou, D. n., Hayrapetyan, Heide, M., Br, Heinz, M., Bt, Helstrup, H. i., Herghelegiu, A. q., Hernández, Herrera, Corral, G., Bl, Herrmann, N., Ar, Hetland, K. F. i., Hicks, B., Bt, Hiei, A., A, Hille, P. T., By, Hippolyte, B., Ct, Horaguchi, T., A, Hori, Y., Cu, Hristov, Hřivnáčová, I., Bx, Hu, S. g., Huang, M. h., Huber, Humanic, T. J., Aa, Hutter, D., Ai, Hwang, D. S., Cp, Ichou, R., B, Ilkaev, R., Co, Ilkiv, I., Dc, Inaba, M., Cx, Innocenti, P. G., An, Ippolitov, M., Bp, Irfan, M. b., Ivan, C., Da, Ivanov, V., Am, Iwasaki, Jachołkowski, Jacobs, P. j., Jančurová, L., Ah, Jangal, S., Ct, Janik, R. o., Jena, C. k., Jena, S., Bq, Jirden, Jones, G. T. l., Jones, P. G. l., Jovanović, P. l., Jung, H., Al, W., Al, Jusko, A. l., Kaidalov, A. B., Bn, Kalcher, Kalićák, P., Bd, Kalisky, Kalliokoski, T., Aw, Kalweit, A., Af, Kamal, A. b., Kamermans, Kanaki, K. h., Kang, E., Al, J. H., Cq, Kapitan, Kaplin, Kapusta, Karavichev, O., Bm, Karavicheva, T., Bm, Karpechev, E., Bm, Kazantsev, A., Bp, Kebschull, U., Aq, Keidel, R., Df, Khan, M. M. b., Khan, S. A., Ba, Khanzadeev, A., Am, Kharlov, Y., Cd, Kikola, D., Dd, Kileng, B. i., Kim, D. J., Aw, D. S., Al, D. W., Al, H. N., Al, J., Cd, J. H., Cp, J. S., Al, M., Al, M., Cq, S. H., Al, S., Cp, Y., Cq, Kirsch, Kisel, I., Aq, Kiselev, S., Bn, Kisiel, A., Aa, Klay, J. L., Cl, Klein, J., Ar, Klein, Bösing, Kliemant, Klovning, A. h., Kluge, Knichel, M. L., Ae, Kniege, S., Aj, Koch, K., Ar, Kolevatov, R., By, Kolojvari, Kondratiev, V., C, Kondratyeva, N., Bo, Konevskih, A., Bm, Kornać, Kour, R. l., Kowalski, M., Ac, Kox, Kozlov, K., Bp, Kral, Králik, I., Bd, Kramer, F., Aj, Kraus, I., Af, Kravćáková, A., Bc, Krawutschke, T., Bb, Krivda, M. l., Krumbhorn, Krus, M., Cb, Kryshen, E., Am, Krzewicki, M. c., Kucheriaev, Y., Bp, Kuhn, C., Ct, Kuijer, P. G. c., Kumar, L. y., Kumar, N. y., Kupczak, R., Dd, Kurashvili, P., Dc, Kurepin, A. N., Bm, Kuryakin, A., Co, Kushpil, S., Cg, V., Cg, Kutouski, M., Ah, Kvaerno, H., By, Kweon, M. J., Ar, Kwon, La, Rocca, P. w., Lackner, Ladrón de, Guevara, Lafage, Lal, C., Av, Lara, C., Aq, Larsen, D. T. h., Laurenti, G. n., Lazzeroni, C. l., Le, Bornec, Y., Bx, Le, Bri, N., B, Lee, H., Cf, K. S., Al, S. C., Al, Lefèvre, F., B, Lenhardt, Leistam, Lehnert, J., Aj, Lenti, V. f., León, H., Bk, León, Monzón, I., Ad, León, Varga, Lévai, P. r., Li, X. g., Li, Y. g., Lietava, R. l., Lindal, S., By, Lindenstruth, Lippmann, Lisa, M. A., Aa, Liu, L. h., Loginov, Lohn, Lopez, X. z., López, Noriega, M., Bx, López, Ramírez, R., Ce, López, Torre, E., Ap, Løvhøiden, Lozea Feijo, Soare, Lu, S. g., Luettig, P., Aj, Lunardon, M., Bz, Luparello, G., Cy, Luquin, Lutz, J. R., Ct, Ma, K., Dg, R., Bt, Madagodahettige, Don, D. M., At, Maevskaya, Mager, M., Af, Mahapatra, D. P. k., Maire, A., Ct, Makhlyueva, I., An, Mal'Kevich, D., Bn, Malaev, M., Am, Malagalage, K. J., Bw, Maldonado, Cervante, Malek, Malkiewicz, Malzacher, Mamonov, Manceau, L. z., Mangotra, L., Av, Manko, Manso, F. z., Manzari, V. f., Mao, Y., Dg, Mareš, J., Cc, Margagliotti, Giacomo, Margotti, A. n., Marín, Martashvili, I., Ay, Martinengo, Martínez, Hernández, M. I., Ce, Martínez, Davalo, Martínez, García, Maruyama, Y., A, Marzari, Chiesa, Masciocchi, Masera, Masetti, M. m., Masoni, A. t., Massacrier, Mastromarco, M. f., Mastroserio, A. e., Matthews, Z. L. l., Matyja, A., Ac, Mayani, D., Bj, Mazza, Mazzoni, M. A., Ci, Meddi, F., Ch, Menchaca, Rocha, Mendez, Lorenzo, Meoni, Mercado, Pérez, Mereu, Miake, Y., Cx, Michalon, Miftakhov, N., Am, Milano, Milosevic, J., By, Minafra, F. e., Mischke, Mićkowiec, D., Ae, Mitu, C. p., Mizoguchi, K., A, Mlynarz, J., Ag, Mohanty, B., Ba, Molnar, L. r., Mondal, M. M., Ba, Montaño, Zetina, L., Bl, Monteno, M., Cz, Montes, E., Bi, Morando, Moretto, S., Bz, Morsch, Moukhanova, T., Bp, Muccifora, V., Ak, Mudnic, E., Cr, Muhuri, Müller, H., An, Munhoz, M. G., Cn, Munoz, J., Ce, Musa, Musso, A., Cz, Nandi, B. K., Bq, Nania, R. n., Nappi, E. f., Navach, F. e., Navin, S. l., Nayak, T. K., Ba, Nazarenko, Nazarov, G., Co, Nedosekin, Nendaz, F., Db, Newby, J., Bg, Nianine, Nicassio, M. f., Nielsen, B. S., Ab, Nikolaev, Nikolic, V., Di, Nikulin, Nilsen, B. S., Bw, Nilsson, M. S., By, Noferini, F. n., Nomokonov, P., Ah, Nooren, G., Da, Novitzky, N., Aw, Nyatha, A., Bq, Nygaard, C., Ab, Nyiri, A., By, Nystrand, J. h., Ochirov, Odyniec, G. j., Oeschler, H., Af, Oinonen, Okada, K., Cu, Oldenburg, Oleniacz, J., Dd, Oppedisano, C., Cz, Orsini, F., Cj, Ortiz, Velasquez, A., Bj, Ortona, Oskarsson, Osmic, Österman, L., Bh, Ostrowski, P., Dd, Otterlund, I., Bh, Otwinowski, J., Ae, Øvrebekk, G. h., Oyama, Ozawa, Pachmayer, Y., Ar, Pachr, Padilla, Pagano, P., Ck, Paić, G., Bj, Painke, F., Aq, Pajares, C., Cm, Pal, S. K., Ba, Palaha, A. l., Palmeri, A. x., Panse, R., Aq, Papikyan, V., Dh, Pappalardo, G. S. x., Park, W. J., Ae, Pastirćák, B., Bd, Pastore, C. f., Paticchio, V. f., Pavlinov, A., Ag, Pawlak, T., Dd, Peitzmann, T., Da, Pepato, Pereira, Peressounko, Pérez, Perini, D., An, Perrino, D. e., Peryt, W., Dd, Peschek, Pesci, A. n., Peskov, V., Bj, Pestov, Y., Bu, Peters, A. J., An, Petráćek, V., Cb, Petridis, A. d., Petris, M. q., Petrov, P. l., Petrovici, M. q., Petta, C. w., Peyré, J., Bx, Piano, Stefano, Piccotti, Pikna, M. o., Pillot, P., B, Pinazza, O. n., Pinsky, L., At, Pitz, N., Aj, Piuz, Platt, R. l., Pćoskoć, M. j., Pluta, Pocheptsov, T., Ah, Pochybova, S. r., Podesta, Lerma, P. L. M., Ad, Poggio, Poghosyan, M. G., Cy, Polák, K., Cc, Polichtchouk, B., Cd, Polozov, P., Bn, Polyakov, Pommeresch, B. h., Pop, A. q., Posa, F. e., Pospíšil, Potukuchi, B., Av, Pouthas, Prasad, Preghenella, R. m., Prino, F., Cz, Pruneau, C. A., Ag, Pshenichnov, I., Bm, Puddu, G. s., Pujahari, P., Bq, Pulvirenti, A. w., Punin, Putiš, Putschke, J., Bt, Quercigh, E., An, Rachevski, A., Cw, Rademakers, Radomski, S., Ar, Räihä, T. S., Aw, Rak, Rakotozafindrabe, Ramello, L. a., Ramírez, Reye, A., Bl, Rammler, Raniwala, R., Au, S., Au, Räsänen, S. S., Aw, Rashevskaya, I., Cw, Rath, S. k., Read, K. F., Ay, Real, J. S., Ao, Redlich, K., Dc, Renfordt, R., Aj, Reolon, A. R., Ak, Reshetin, Rettig, Revol, J. P., An, Reygers, K., Br, Ricaud, Riccati, L., Cz, Ricci, R. A., Be, Richter, M. h., Riedler, Riegler, Riggi, F. w., Rivetti, Rodriguez, Cahuantzi, M., Ce, Røed, K. i., Röhrich, Román, López, S., Ce, Romita, R. e., Ronchetti, F., Ak, Rosinskỳ, Rosnet, P. z., Rossegger, Rossi, A., Cv, Roukoutakis, Rousseau, S., Bx, Roy, C., B, P., Az, Rubio, Montero, A. J., Bi, Rui, Rinaldo, Rusanov, I., Ar, Russo, G., Ck, Ryabinkin, E., Bp, Rybicki, Sadovsky, S., Cd, Šafaćík, K., An, Sahoo, R., Bz, Saini, J., Ba, Saiz, Sakata, D., Cx, Salgado, C. A., Cm, Salgueiro Domingues da, Silva, Salur, S. j., Samanta, T., Ba, Sambyal, S., Av, Samsonov, Šándor, L., Bd, Sandoval, Sano, S., Cu, Santo, Santoro, R. e., Sarkamo, Saturnini, P. z., Scapparone, E. n., Scarlassara, F., Bz, Scharenberg, R. P., De, Schiaua, C. q., Schicker, Schindler, Schmidt, H. R., Ae, Schossmaier, Schreiner, Schuchmann, Schukraft, Schutz, Y., B, Schwarz, K., Ae, Schweda, Scioli, G. m., Scomparin, E., Cz, Scott, P. A. l., Segato, G., Bz, Semenov, Senyukov, S. a., Seo, J., Al, Serci, S. s., Serkin, Serradilla, Sevcenco, A. p., Sgura, I. e., Shabratova, G., Ah, Shahoyan, Sharkov, G., Bn, Sharma, N. y., Sharma, Shigaki, Shimomura, Shtejer, K., Ap, Sibiriak, Siciliano, Sicking, Siddi, E. t., Siemiarczuk, Silenzi, A. m., Silvermyr, D., Bv, Simili, E., Da, Simonetti, G. e., Singaraju, R., Ba, Singh, Singhal, V., Ba, Sinha, B. C., Ba, T., Az, Sitar, B. o., Sitta, M. a., Skaali, T. B., By, Skjerdal, K. h., Smakal, R., Cb, Smirnov, N., Bt, Snellings, R. c., Snow, H. l., Søgaard, Soloviev, A., Cd, Soltveit, H. K., Ar, Soltz, R., Bg, Sommer, W., Aj, Son, C. W., Cf, H., Cp, Song, Soos, Soramel, Soyk, Spyropoulou, Stassinaki, M. d., Srivastava, B. K., De, Stachel, Staley, Stan, E. p., Stefanek, G., Dc, Stefanini, Steinbeck, Stenlund, E., Bh, Steyn, G. v., Stocco, D., Cy, Stock, Stolpovsky, P., Cd, Strmen, P. o., Suaide, A. A. P., Cn, Subieta, Vásquez, M. A., Cy, Sugitate, Suire, Šumbera, M., Cg, Susa, Swoboda, Symons, J. j., Szanto de, Toledo, Szarka, I. o., Szostak, A. t., Szuba, M., Dd, Tadel, Tagridis, C. d., Takahara, A., Cu, Takahashi, J. u., Tanabe, R., Cx, Tapia, Takaki, J. D., Bx, Taureg, Tauro, Tavlet, Tejeda, Muñoz, G., Ce, Telesca, Terrevoli, C. e., Thäder, Tieulent, R., Db, Tlusty, D., Cb, Toia, Tolyhy, T. r., Torcato de, Mato, Torii, H., A, Torralba, G., Aq, Toscano, Tosello, Tournaire, A., B, Traczyk, Tribedy, Tröger, Truesdale, D., Aa, Trzaska, W. H., Aw, Tsiledakis, G., Ar, Tsilis, E. d., Tsuji, Tumkin, Turrisi, R., Ca, Turvey, A., Bw, Tveter, T. S., By, Tydesjö, Tywoniuk, Ulery, Ullaland, K. h., Uras, A. s., Urbán, J., Bc, Urciuoli, G. M., Ci, Usai, G. L. s., Vacchi, Vala, Valencia, Palomo, L., Bk, Vallero, van der, Kolk, N., C., Vande, Vyvre, Van, Leeuwen, Vannucci, L., Be, Vargas, Varma, R., Bq, Vasiliev, Vassiliev, Vasileiou, M. d., Vechernin, Venaruzzo, Massimo, Vercellin, Vergara, Vernet, R. w., Verweij, Vetlitskiy, I., Bn, Vickovic, L., Cr, Viesti, Vikhlyantsev, O., Co, Vilakazi, Z. v., Villalobos, Baillie, O. l., Vinogradov, Vinogradov, L., C, Y., Co, Virgili, T., Ck, Viyogi, Y. P., Ba, Vodopianov, Voloshin, K., Bn, S., Ag, Volpe, G. e., Von, Haller, B., An, Vranic, Vrláková, Vulpescu, B. z., Wagner, B. h., Wagner, Wallet, Wan, R., Dg, Wang, D., Dg, Watanabe, K., Cx, Wen, Q. g., Wessels, J., Br, Westerhoff, U., Br, Wiechula, Wikne, Wilk, A., Br, Williams, M. C. S. n., Willis, N., Bx, Windelband, B., Ar, Xu, C., Dg, Yang, H., Ar, Yasnopolskiy, Yermia, Yi, J., Cf, Yin, Z., Dg, Yokoyama, H., Cx, Yoo, I. K., Cf, Yuan, Yurevich, V., Ah, Yushmanov, I., Bp, Zabrodin, E., By, Zagreev, B., Bn, Zalite, Zampolli, Zanevsky, Y., Ah, Zaporozhets, Zarochentsev, Závada, P., Cc, Zbroszczyk, H., Dd, Zelnicek, P., Aq, Zenin, Zepeda, Zgura, I. p., Zhalov, Zhang, Zhou, Zhou, S. g., Zhu, J., Dg, Zichichi, A. m., Zinchenko, Zinovjev, G., Ax, Zoccarato, Y., Db, Zycháćek, and Zynovyev, M.
- Subjects
ALICE ,LHC ,Transverse momentum ,pp ,900 GeV ,PYTHIA ,High Energy Physics::Experiment ,Nuclear Experiment - Abstract
The inclusive charged particle transverse momentum distribution is measured in proton–proton collisions at s=900 GeV at the LHC using the ALICE detector. The measurement is performed in the central pseudorapidity region (|η
- Full Text
- View/download PDF
133. Dual Effects of Plant Antioxidants on Neuron Cell Viability
- Author
-
SO Norfaizatul, CZ Zetty Akmal, AK Noralisa, SM Then, WN Wan Zurinah, and M Musalmah
- Subjects
antioxidant ,centella asiatica ,chlorella vulgaris ,momordica charantia ,neuroprotection ,piper betl ,Therapeutics. Pharmacology ,RM1-950 ,Toxicology. Poisons ,RA1190-1270 - Abstract
Background : Many studies have focused on oxidative stress induced damage and hence, the protective effects conferred by antioxidants. An example is neurodegenerative diseases which is thought to occur due to neuronal loss associated with oxidative stress. However, some antioxidants such as vitamin E have been shown to also exert pro-oxidative effects at high concentration. Objective : In this study the cytotoxicity and neuroprotective potentials of Chlorella vulgaris (CV), Momordica charantia (MC) and Piper betle (PB) were investigated and correlated with the antioxidant potential. Tocotrienol Rich Fraction (TRF) served as positive control since it had been shown previously to have high antioxidant potential as well as to exert neuroprotective and neurocytotoxic effects. Method : Free radical scavenging activities of hot water extract of CV, aqueous extract of MC, aqueous extract of PB and TRF were determined by using DPPH (1, 1-diphenyl-2-picryl-hydrazyl) assay. Cytotoxicity and neuroprotective effects were measured by using 3 - (4, 5 -dimethylthiazol-2-yl) -5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) against BSO-induced neuron cell death. Results : Results showed that TRF has the highest radical scavenging activity followed PB> MC> CV. The MTS results showed that TRF (1-50 µg/ml) as positive control, PB (0.001-100µg/ml) and MC (1-500µg/ml) conferred significant protection against BSO-induced cell death. These plants were cytotoxic at high concentrations. However CV extract did not show significant neuroprotective effect against BSO-induced cell death nor cytotoxic effect. Conclusion : The present findings showed that plant extracts with the higher free radical scavenging activity showed neuroprotective effects at low concentrations but were cytotoxic at higher concentrations.
- Published
- 2010
134. VizieR Online Data Catalog: SDSS/BOSS/TDSS CIV BAL quasars (Grier+, 2016)
- Author
-
Grier, C. J., Brandt, W. N., Hall, P. B., Trump, J. R., Filiz, Ak N., Anderson, S. F., Green, P. J., Schneider, D. P., Sun, M., Vivek, M., Beatty, T. G., Joel Brownstein, and Roman-Lopes, A.
135. VizieR Online Data Catalog: SDSS quasar catalog: tenth data release (Paris+, 2014)
- Author
-
Paris, I., Petitjean, P., Aubourg, E., Ross, N. P., Myers, A. D., Strblyanska, A., Bailey, S., Hall, P. B., Strauss, M. A., Anderson, S. F., Bizyaev, D., Borde, A., Brinkmann, J., Bovy, J., Brandt, W. N., Brewington, H., Browstein, J. R., Benjamin Cook, Ebelke, G., Fan, X., Filiz, Ak N., Finley, H., Font-Ribera, A., Ge, J., Hamann, F., Ho, S., Jiang, L., Kinemuchi, K., Malanushenko, E., Malanushenko, V., Marchante, M., Mcgreer, I. D., Mcmahon, R. G., Miralda-Escude, J., Muna, D., Noterdaeme, P., Oravetz, D., Palanque-Delabrouille, N., Pan, K., Perez-Fournon, I., Pieri, M., Riffel, R., Schlegel, D. J., Schneider, D. P., Simmons, A., Viel, M., Weaver, B. A., Wood-Vasey, W. M., Yeche, C., and York, D. G.
136. Trichomonas Vaginalis infection among women in Ikwuano Abia State Nigeria.
- Author
-
ANC Amadi and AK Nwagbo
- Subjects
Science - Abstract
A study on Trichomoniasis was conducted to determine the prevalence, symptoms and factors that promote the transmission of Trichomonas vaginalis among women of Ikwuano in Abia State using high vaginal swab and urine samples. A total of 600 women aged between 14-60years were examined and 112 (18.67%) were infected with Trichomoniasis. The highest prevalence of Trichomonas vaginalis infection (20.57%) was observed among the age group of 21-30 years, the least (7.8%) was observed among those of 41-50years while 51-60 age group had no infection at all. Occupational related prevalence revealed that traders had the highest (30%) followed by students (19.78%), civil servants (15.66%) and house wives had the least (8.33%). In relation to marital status, single women had the highest (19.72%). While widows had the least (9.09%). Symptomatic individuals had characteristic symptoms such as itching/rashes (3.83%), Genital sores (2.88%), Hot feeling sensation (4.50%), Greenish yellow discharge (6.00%), while very few had no symptom at all. Lack of hygiene, ignorance poverty, prosmocuity and factors influencing the transmission. Trichomonas vaginalis is a common sexually transmitted disease among women in Ikwuano Abia State. Proper sex education especially for the adolescent and youths should be intensified so as to ensure a population fully aware of the medical implications of STD and hence reduce the spread and other health complications as a result of the infection.
- Published
- 2013
- Full Text
- View/download PDF
137. Awareness About Vaccine Vial Monitor at Pulse Polio Booths
- Author
-
Bipin Vasava, Kallol Malick, Kairavee Dave, Amit Patel, Mihir Rupani, Bhautik Modi, and AK Naik
- Subjects
Pulse polio ,Vaccine vial monitor ,Public aspects of medicine ,RA1-1270 - Abstract
NA
- Published
- 2010
138. Factors influencing emergency delays in acute stroke management
- Author
-
AC Griesser, G Wagner, AK Njamnshi, P Temperli, and M Niquille
- Subjects
Stroke management ,Acute care ,Admission delays ,stroke ,Medicine - Published
- 2009
- Full Text
- View/download PDF
139. Pseudoexfoliative Glaucoma in a Patient with Toxic Optic Atrophy and Cupping
- Author
-
Ali Ayd›n, Ümit Aykan, Ak›n Çak›r, Taner Kar, and Dilaver Erşanlı
- Subjects
Optic disc cupping ,methanol intoxication ,pseudoexfoliation glaucoma ,Medicine ,Ophthalmology ,RE1-994 - Abstract
A 57-year-old man, who had developed bilateral symmetric optic atrophy and cupping due to methanol intoxication nine years ago, noticed slowly progressive visual impairment in the left eye (OS). In ophthalmic examination, visual acuity was 20/60 in the right eye (OD) and ‘hand motion’ in OS. Intraocular pressure was 20 in OD and 28mmHg in OS. Anterior segment biomicroscopy showed bilateral pseudoexfoliation, more intense in OS. Ophthalmoscopy revealed bilaterally deep and wide cupping with cup-to-disc ratios of 8/10 in OD and approximately 10/10 in OS. Based on these findings, the diagnosis of left pseudoexfoliative glaucoma, in addition to bilateral toxic optic atrophy and cupping, was made. Pathological optic-disc cupping may be caused by many conditions other than glaucoma. In these cases, glaucoma may aggravate the both cupping and atrophy. (Turk J Ophthalmol 2011; 41: 256-9)
- Published
- 2011
- Full Text
- View/download PDF
140. The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
- Author
-
YUMUK, PERRAN FULDEN, Eralp, Y., Ak, N., Yilmazbayhan, D., Ozkan, B., Ferhatoglu, F., Demirkazik, A., Sak, S. Dizbay, Dilege, S., Tanju, S., Toker, A., Bulutay, P., Firat, P., Mandel, N. Molinas, Kilickap, S., Onder, S., Dikmen, E., Alan, O., Yumuk, P. F., Bozkurtlar, E., Lacin, T., Ozturk, A., Kocaturk, C., Karapinar, K., Urer, N., and Uluc, B. Oyan
- Subjects
Early Stage ,Adjuvant Chemotherapy ,NSCLC - Published
- 2019
141. Prevalence of masked hypertension in children with chronic kidney disease: a cross-sectional study.
- Author
-
Ak N, Satapathy AK, John J, Pati AB, Kar M, and Sahu S
- Abstract
Background: Hypertension poses a significant risk as a complication of chronic kidney disease (CKD), contributing to its hastened advancement. Implementing ambulatory blood pressure monitoring (ABPM), a straightforward and non-invasive method proves beneficial in identifying masked hypertension., Methods: A cross-sectional study was carried out involving children aged 5-15 years diagnosed with CKD to estimate the difference in masked HTN prevalence between the 2014 and 2022 AHA ABPM guidelines. The study encompassed a comprehensive assessment, including 24-h blood pressure monitoring and was performed using ABPM. Left ventricular mass (LVM) was computed based on measurements obtained from M-mode echocardiography. PWV was determined by calculating the ratio of distance (D) to time (t)., Results: We examined a cohort of 138 children diagnosed with CKD. Our findings reveal that, in accordance with the 2022 American Heart Association (AHA) ABPM guidelines, prevalence of masked hypertension stands at 29.7% marking a notable increase of 17.4% compared to the 2014 ABPM guidelines signifying a substantial proportion of undetected hypertensive cases. Furthermore, the prevalence of hypertension is 48.5% as detected by ABPM, marking a notable increase of 22.5%., Conclusions: A substantial occurrence of masked hypertension was identified in pediatric CKD patients through the application of ABPM. ABPM proves to be an effective tool for uncovering masked hypertension in children with CKD., Competing Interests: Declarations. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institute Ethics Committee of AIIMS Bhubaneswar (IEC/AIIMS BBSR/PG Thesis/21–22/44). Consent to participate: Written informed consent was obtained from the parents. Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to International Pediatric Nephrology Association.)
- Published
- 2024
- Full Text
- View/download PDF
142. Electrostatic Modulation for Enhanced Ion Selectivity in Gate-All-Around Multilayer Stacked Graphene Nanopore.
- Author
-
Ak N and Kumar S
- Abstract
Biological ion channels exhibit exceptional gating capabilities for regulated transport and filtration across cell membranes. This study explores similar gating functions in artificial nanopores using graphene membranes. By applying direct voltage, we can dynamically control ion distribution around nanopores, allowing for real-time triggering, dynamic flow control, and adaptability to varying pore sizes. We investigate electrostatic modulation of ion transport in a stacked nanoporous graphene configuration, which mitigates defects from growth and transfer processes. Nanopores are created using oxygen plasma, enabling fine-tuning of ion transport. External voltage enhances ion conductivity at positive voltages and reduces it at negative voltages, demonstrating significant modulation by the surface potential-induced electric double layer (EDL). Voltage-dependent ion enrichment and depletion within the nanopores affect the effective surface charge density, facilitating controllable ion sieving. Results show that nanopores, with sizes comparable to hydrated ion diameters, achieve high and tunable voltage-gating functionality, enabling efficient on-demand ion transport. Voltage-gating effectively tunes ion selectivity in multilayer stacked graphene membranes, with negative voltages impeding divalent cations and positive voltages mimicking biological K
+ nanochannels. This research lays the foundation for developing nanopores with tunable ion selectivity for applications in energy conversion, ion separation, and nanofluidics.- Published
- 2024
- Full Text
- View/download PDF
143. Delay in Time to Adjuvant Chemotherapy and its Impact on Oncological Outcomes in Patients Undergoing Optimal Cytoreductive Surgery for Advanced Ovarian Cancer: Analysis of 1480 Cases From the Indian HIPEC Registry.
- Author
-
Sp S, C RK, Kr A, Y R, N AK, Fernandez AM, and Ahuja V
- Abstract
Background and Objectives: The impact of delay in initiation of adjuvant chemotherapy following optimal CRS in different settings of treatment for advanced ovarian cancer needs to be studied with special reference to CRS HIPEC., Methods: The 1480 advanced EOC patients underwent optimal CRS, followed by adjuvant chemotheraphy, with or without intraperitoneal (IP) chemotherapy in Normothermic or Hyperthermic form. Interval between the day of surgery and start of adjuvant chemotherapy and its impact on outcome was analyzed., Results: CRS, CRS with IP or HIPEC was done in 400, 480, and 600 patients respectively. Median interval of starting adjuvant chemotherapy was 32 days CRS group, 34 days CRS + IP group and 41 days CRS + HIPEC group. Delay in chemotherapy impacted on recurrence free survival (RFS) in CRS + IV group (36 vs. 17 months: p = 0.02) and some impact in CRS + IP group (38 vs. 28 months; P 0.78) and no impact on CRS + HIPEC group (35 vs. 32 months; p = 0.17)., Conclusions: Delay in starting adjuvant chemotherapy adversely affects RFS in patients undergoing optimal CRS alone. However, the delay didn't have an impact in the CRS + HIPEC group. Well-designed clinical studies are required to evaluate the impact of single dose of HIPEC., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
144. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.
- Author
-
Dülgar Ö, Türker S, Başaran G, Araz M, Sümbül AT, Çağlayan D, Gümüşay Ö, Biter S, Konca A, Özen M, Demir H, Özdemir M, Karataş F, Şahin E, Çavdar E, Yasin Aİ, Yaşar A, Derin S, Pehlivan M, Üyetürk Ü, Özdemir Ö, Kayıkçıoğlu E, Ak N, Şakalar T, Sakin A, Büyükşimşek M, Ay S, Ertürk İ, Akbaş S, Bir Yücel K, and Gümüş M
- Abstract
We aimed to evaluate the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab plus trastuzumab and taxane. We reviewed the medical records of patients who were diagnosed with Human Epidermal Growth Factor Receptor 2 (HER-2) positive metastatic breast cancer and received pertuzumab and then TDM-1 between January 2014 and January 2021 from twenty- five cancer centers. The Kaplan- Meier method estimated progression-free survival (PFS) and overall survival (OS). Additionally, objective response rate (ORR), clinical benefit rate (CBR), and safety were evaluated. One hundred fifty-three patients were included,79.1% of the patients received TDM-1 in the second line, 90.8% had visceral metastasis, and 30.7% had central nervous system involvement. The PFS and OS of TDM-1 were evaluated according to the number of previous lines (on the 2nd line or more than two lines) metastatic sites (visceral and non-visceral) and the presence of central nervous metastasis. In TDM-1 therapy, PFS in second line therapy was ten months (95% CI: 7.7 - 12.2); this was statistically higher than later-line PFS, which was six months (95% CI: 3.3 to 8.6) ( p = 0.004). The median OS time was 25 months (95% CI: 21.0 to 28.9) in patients treated with TDM-1 in the second line and 19 months (95% CI: 12.3 to 25.6) in patients who received later than the second line( p = 0.175). There were no significant differences in PFS time of patients with and without visceral and central nervous metastases. Our study showed that TDM-1 was also effective in patients using pertuzumab, contributes significantly to PFS when used in the second line compared to its use in the later line, and does not make any difference in OS.
- Published
- 2024
- Full Text
- View/download PDF
145. Acetylresveratrol (AC-Res): An Evolving Frontier in Modulating Gene Expression.
- Author
-
Panigrahy UP, Buchade RS, S S, N AK, Gunjal SD, Selvakumari E, Pandey NK, and Wal A
- Abstract
Background: Acetylresveratrol (AC-Res), to date, is a powerful stilbene phytoalexin generated organically or as a component of a plant's defensive system, is a significant plant phenolic chemical portion and is investigated as a therapy option for a number of disorders. Owing to its inadequate stabilisation and considerable conformation rigidity, the utility of AC-Res as a medication is limited., Objective: The current review article outlined the structure of AC-Res, their methods of activity, and the latest technological progress in the administration of these molecules. It is conceivable to deduce that AC-Res has a variety of consequences for the cellular functions of infected cells., Methods: The literature survey for the present article was gathered from the authentic data published by various peer-reviewed publishers employing Google Scholar and PubMedprioritizing Scopus and Web of Science indexed journals as the search platform focusing on AC-Res pharmacological actions, particularly in the English language., Result: Despite its extensive spectrum of biological and therapeutic applications, AC-Res has become a source of increasing concern. Depending on the researchers, AC-Res possesses radioprotective, cardioprotective, neurological, anti-inflammatory, and anti-microbial potential. It also has anti-cancer and antioxidant properties., Conclusion: To avoid non-specific cytotoxicity, optimization efforts are presently emphasizing the possible usage of AC-Res based on nanocrystals, nanoparticles and dendrimers, and nanocrystals. Finally, while using AC-Res in biology is still a way off, researchers agree that if they continue to explore it, AC-Res and similar parts will be recognized as actual possibilities for a variety of things in the next years., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
146. Evaluation of Hepatitis A and B Seroprevalences in Health-Care Workers.
- Author
-
Utku ES and Ak N
- Abstract
Background: Viral hepatitis is still a common and important public health problem for health-care workers around the world and in our country. This study was aimed at determining the immunity status of hepatitis B and hepatitis A in order to vaccinate non-immune workers., Methods: The population of this cross-sectional descriptive study, which was conducted retrospectively, consists of all health-care workers who applied to the Occupational Health and Safety Department of the hospital between September 1, 2022, and December 31, 2022, for periodic examination. The files of 1652 health-care workers were examined without selecting the sample and these individuals were included in the study. "Annex 2 form," which was delivered to the employees, was used as a data source in the research. Statistical analyses were performed by Statistical Package for the Social Sciences Statistics software (SPSS Inc.; Chicago, IL, USA), version 15.0., Results: In our study, the immunity against hepatitis B in the 18-29 age group, women, singles, and university graduates was statistically significantly higher, and the immunity against hepatitis A of the participants aged 50 and over, men, and primary school graduates was statistically significant and was found to be significantly higher (P <.05)., Conclusion: The fact that 90.2% of the participants were immune to hepatitis B and 85.0% of the participants were immune to hepatitis A seems to be related to the success of vaccination programs for health-care workers in our country. It is very important that the immunization status of health-care workers, who are in the high-risk group in terms of infectious diseases, is at the desired level.
- Published
- 2024
- Full Text
- View/download PDF
147. Bacterial Colonization of Mobile Phones: Myth or Reality.
- Author
-
Sure SS, Narayanan CD, N AK, and Chandramohan N
- Abstract
Introduction Bacteria tend to persist on mobile phones for longer durations causing hospital-acquired infections. This is primarily because mobile phones have become an extended hand to healthcare workers due to their unavoidable utilization and the lack of sanitization after use in wards. Methods A questionnaire was used to assess the usage and disinfection practices of mobile phones among medical students regularly attending the wards of a teaching hospital. Culture was done to assess the presence of bacteria and their resistance to antibiotics. Three sterile cotton swabs were performed for each mobile phone. If growth was present, then a culture smear was made, and the type of bacteria was assessed. Participants received subsequent education on the disinfection of phones according to standard disinfection protocol. The main objective of the study was to determine the presence of bacteria on students' mobile phones and its resistance to antibiotics. Results A total of 103 medical students took part in the study, which included 51 males and 52 females. It was found that all the students used their mobile phones at all times in wards and 43% of them carried their phones to washrooms. Out of all the students surveyed, only 23% of students had regularly disinfected their phones. Bacteria were present on all mobile phones sampled. Among these, 98.05% had Gram-positive bacteria, 82.52% had Gram-negative bacilli, 33.98% had Bacillaceae, and 8.73% had vancomycin-resistant enterococcus (VRE). Among participants who did not disinfect their phones, 95.89% and 97.59% had methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA), respectively. Conclusion Following standard disinfection protocols is the need of the hour to reduce hospital-acquired infections., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Sure et al.)
- Published
- 2024
- Full Text
- View/download PDF
148. Integration of 2D Nanoporous Membranes in Microfluidic Devices.
- Author
-
Ak N and Kumar S
- Abstract
2D material-based membranes have emerged as promising candidates for next-generation separation technology due to their exceptional permeability and selectivity. Integration of these membranes into microfluidic devices has offered significant potential for improving the efficiency, throughput, and precision. However, designing compact and reliable microfluidic devices with membranes has many challenges, including complexities in membrane integration, analyte measurement, and contamination issues. Addressing these challenges is critical for unlocking the full potential of membrane-integrated devices. This paper proposes a systematic procedure for integrating membranes into a microfluidic device by creating a pore in the middle layer. Furthermore, an ion transport experiment is carried out across various stacked graphene and poly carbonate track etch membranes in an Ostemer-based device. The resulting device is capable of facilitating the concurrent measurement, a task that is cumbersome in standard macroscopic diffusion cells. The transparency and compactness of the microfluidic device allowed for the in situ and real-time optical characterization of analytes. The integration of microfluidic devices with 2D nanoporous membranes has enabled the incorporation of several analytical modalities, resulting in a highly versatile platform with numerous applications., Competing Interests: The authors declare no competing financial interest., (© 2024 The Authors. Published by American Chemical Society.)
- Published
- 2024
- Full Text
- View/download PDF
149. Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma.
- Author
-
Tompkins A, Gray ZN, Dadey RE, Zenkin S, Batavani N, Newman S, Amouzegar A, Ak M, Ak N, Pak TY, Peddagangireddy V, Mamindla P, Behr S, Goodman A, Ploucha DL, Kirkwood JM, Zarour HM, Najjar YG, Davar D, Colen R, Luke JJ, and Bao R
- Abstract
Background: Variability in treatment response may be attributable to organ-level heterogeneity in tumor lesions. Radiomic analysis of medical images can elucidate non-invasive biomarkers of clinical outcome. Organ-specific radiomic comparison across immunotherapies and targeted therapies has not been previously reported., Methods: We queried UPMC Hillman Cancer Center registry for patients with metastatic melanoma (MEL) treated with immune checkpoint inhibitors (ICI) (anti-PD1/CTLA4 [ipilimumab+nivolumab; I+N] or anti-PD1 monotherapy) or BRAF targeted therapy. Best overall response was measured using RECIST v1.1. Lesions were segmented into discrete volume-of-interest with 400 radiomics features extracted. Overall and organ-specific machine-learning models were constructed to predict disease control (DC) versus progressive disease (PD) using XGBoost., Results: 291 MEL patients were identified, including 242 ICI (91 I+N, 151 PD1) and 49 BRAF. 667 metastases were analyzed, including 541 ICI (236 I+N, 305 PD1) and 126 BRAF. Across cohorts, baseline demographics included 39-47% female, 24-29% M1C, 24-46% M1D, and 61-80% with elevated LDH. Among patients experiencing DC, the organs with the greatest reduction were liver (-88%±12%, I+N; mean±S.E.M.) and lung (-72%±8%, I+N). For patients with multiple same-organ target lesions, the highest inter-lesion heterogeneity was observed in brain among patients who received ICI while no intra-organ heterogeneity was observed in BRAF. 267 patients were kept for radiomic modeling, including 221 ICI (86 I+N, 135 PD1) and 46 BRAF. Models consisting of optimized radiomic signatures classified DC/PD across I+N (AUC=0.85) and PD1 (0.71) and within individual organ sites (AUC=0.72∼0.94). Integration of clinical variables improved the models' performance. Comparison of models between treatments and across organ sites suggested mostly non-overlapping DC or PD features. Skewness, kurtosis, and informational measure of correlation (IMC) were among the radiomic features shared between overall response models. Kurtosis and IMC were also utilized by multiple organ-site models., Conclusions: Differential organ-specific response was observed across BRAF and ICI with within organ heterogeneity observed for ICI but not for BRAF. Radiomic features of organ-specific response demonstrated little overlap. Integrating clinical factors with radiomics improves the prediction of disease course outcome and prediction of tumor heterogeneity.
- Published
- 2024
- Full Text
- View/download PDF
150. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.
- Author
-
Minareci Y, Ak N, Sozen H, Tosun OA, Kucukgergin C, Aydin F, Bingul İ, Salihoglu MY, and Topuz S
- Subjects
- Humans, Female, Carcinoma, Ovarian Epithelial diagnosis, Carcinoma, Ovarian Epithelial genetics, Biomarkers, Tumor genetics, Real-Time Polymerase Chain Reaction, Gene Expression Regulation, Neoplastic genetics, MicroRNAs metabolism, Ovarian Neoplasms diagnosis, Ovarian Neoplasms genetics, Ovarian Neoplasms pathology, Neoplasms, Glandular and Epithelial diagnosis, Neoplasms, Glandular and Epithelial genetics
- Abstract
Aim: Epithelial ovarian cancer (EOC) is the most ominous tumor of gynecological cancers due to its poor early detection rate and unfavorable prognosis. To date, there is no reliable screening method for the diagnosis of ovarian cancer at an early stage. MiRNAs are small non-coding RNA molecules, and their main function is to regulate gene expression. The present study compared the serum miR-1181 and miR-4314 levels in patients with EOC and healthy controls to measure the diagnostic and prognostic value as candidate biomarkers., Materials and Methods: We collected serum samples from a total of 135 participants (69 patients with EOC and 66 healthy controls). Relative expressions of miR-1181 and miR-4314 were measured by quantitative real-time polymerase chain reaction assay (qPCR)., Results: The present study revealed that both serum miR-1181 and miR-4314 levels in patients with EOC were significantly increased compared to healthy controls for each marker. In addition, there was a significant relationship between miR-1181 and miR-4314 overexpressions and the stage and prognosis of the disease. Finally, patients with high expression levels of miR-1181 and miR-4314 had significantly shorter survival rates than those with low expression levels., Conclusion: The current study proposed that serum miR-1181 and miR-4314 could discriminate the EOC patients from healthy controls. In addition, both miR-1181 and miR-4314 may be predictive biomarkers for ovarian cancer prognosis. Further studies are needed to confirm the findings of the present study., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.